<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7731202</article-id><article-id pub-id-type="pmid">33287261</article-id><article-id pub-id-type="doi">10.3390/molecules25235709</article-id><article-id pub-id-type="publisher-id">molecules-25-05709</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Lignans and Gut Microbiota: An Interplay Revealing Potential Health Implications</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1534-4119</contrib-id><name><surname>Senizza</surname><given-names>Alice</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05709">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3488-4513</contrib-id><name><surname>Rocchetti</surname><given-names>Gabriele</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05709">1</xref><xref rid="c1-molecules-25-05709" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Mosele</surname><given-names>Juana I.</given-names></name><xref ref-type="aff" rid="af2-molecules-25-05709">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8825-3384</contrib-id><name><surname>Patrone</surname><given-names>Vania</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05709">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7811-5305</contrib-id><name><surname>Callegari</surname><given-names>Maria Luisa</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05709">1</xref></contrib><contrib contrib-type="author"><name><surname>Morelli</surname><given-names>Lorenzo</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05709">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5133-9464</contrib-id><name><surname>Lucini</surname><given-names>Luigi</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05709">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Jurgo&#x00144;ski</surname><given-names>Adam</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Fotschki</surname><given-names>Bartosz</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Sawicki</surname><given-names>Tomasz</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-05709"><label>1</label>Department for Sustainable Food Process, Universit&#x000e0; Cattolica del Sacro Cuore, via Emilia Parmense 84, 29122 Piacenza, Italy; <email>alice.senizza@unicatt.it</email> (A.S.); <email>vania.patrone@unicatt.it</email> (V.P.); <email>marialuisa.callegari@unicatt.it</email> (M.L.C.); <email>lorenzo.morelli@unicatt.it</email> (L.M.); <email>luigi.lucini@unicatt.it</email> (L.L.)</aff><aff id="af2-molecules-25-05709"><label>2</label>C&#x000e1;tedra de Fisicoqu&#x000ed;mica, Departamento de Qu&#x000ed;mica Anal&#x000ed;tica y Fisicoqu&#x000ed;mica, Facultad de Farmacia y Bioqu&#x000ed;mica, Universidad de Buenos Aires, Buenos Aires C1113AAD, Argentina; <email>xuanif@hotmail.com</email></aff><author-notes><corresp id="c1-molecules-25-05709"><label>*</label>Correspondence: <email>gabriele.rocchetti@unicatt.it</email></corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2020</year></pub-date><volume>25</volume><issue>23</issue><elocation-id>5709</elocation-id><history><date date-type="received"><day>12</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>02</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Plant polyphenols are a broad group of bioactive compounds characterized by different chemical and structural properties, low bioavailability, and several in vitro biological activities. Among these compounds, lignans (a non-flavonoid polyphenolic class found in plant foods for human nutrition) have been recently studied as potential modulators of the gut&#x02013;brain axis. In particular, gut bacterial metabolism is able to convert dietary lignans into therapeutically relevant polyphenols (i.e., enterolignans), such as enterolactone and enterodiol. Enterolignans are characterized by various biologic activities, including tissue-specific estrogen receptor activation, together with anti-inflammatory and apoptotic effects. However, variation in enterolignans production by the gut microbiota is strictly related to both bioaccessibility and bioavailability of lignans through the entire gastrointestinal tract. Therefore, in this review, we summarized the most important dietary source of lignans, exploring the interesting interplay between gut metabolites, gut microbiota, and the so-called gut&#x02013;brain axis.</p></abstract><kwd-group><kwd>phenolic compounds</kwd><kwd>bioaccessibility</kwd><kwd>enterolignans</kwd><kwd>gut microbiota</kwd><kwd>gut&#x02013;brain axis</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-05709"><title>1. Introduction</title><p>In the last years, research efforts have been devoted to the characterization of polyphenols and their metabolites in different biofluids related to potential health-promoting properties [<xref rid="B1-molecules-25-05709" ref-type="bibr">1</xref>]. In this regard, a phenolic-rich diet is suggested to provide health benefits for the consumers, mainly when considering protection against oxidative stress and other diseases (Rothwell et al., 2016). Phenolic compounds are classified as plant secondary metabolites, characterized by a chemically diverse group of bioactive compounds and comprising several subclasses like flavonoids, phenolic acids, lignans, stilbenes, and other compounds (such as tyrosol derivatives and tannins, respectively) [<xref rid="B2-molecules-25-05709" ref-type="bibr">2</xref>].</p><p>Among polyphenols, lignans have been widely studied due to their steroid-analogous chemical structure, being recognized as phytoestrogens, and possessing various biological properties, including anti-inflammatory and antioxidant properties [<xref rid="B3-molecules-25-05709" ref-type="bibr">3</xref>,<xref rid="B4-molecules-25-05709" ref-type="bibr">4</xref>,<xref rid="B5-molecules-25-05709" ref-type="bibr">5</xref>]. Additionally, epidemiological studies observed that lignans decrease the risk of cardiovascular disease [<xref rid="B6-molecules-25-05709" ref-type="bibr">6</xref>], whilst other widely studied effect on chronic diseases (such as breast cancer) are still not fully confirmed.</p><p>The presence of lignans in the plant kingdom follows a similar pattern of distribution to other phenolic compounds. There are particularly rich dietary sources of lignans, such as oilseeds (flaxseed, sesame, linseed, and sunflower), whilst other foods present moderate to low amounts [<xref rid="B7-molecules-25-05709" ref-type="bibr">7</xref>]. Nevertheless, dietary surveys have observed that whole grains (especially rye), legumes, fruits, vegetables, nuts, and some beverages such as tea and coffee, can be considered good dietary sources of these compounds [<xref rid="B8-molecules-25-05709" ref-type="bibr">8</xref>,<xref rid="B9-molecules-25-05709" ref-type="bibr">9</xref>]. Starting from the previous considerations, it seems clear that the characteristics of the diet will define the degree of exposition to plant lignans. Due to their large occurrence in foods, the most studied compounds are secoisolariciresinol, matairesinol, lariciresinol, pinoresinol, medioresinol, syringaresinol, and sesamin, which are predominantly present as glucosides as secoisolariciresinol diglucoside and pinoresinol diglucoside [<xref rid="B7-molecules-25-05709" ref-type="bibr">7</xref>,<xref rid="B10-molecules-25-05709" ref-type="bibr">10</xref>,<xref rid="B11-molecules-25-05709" ref-type="bibr">11</xref>].</p><p>As widely reviewed in the scientific literature [<xref rid="B12-molecules-25-05709" ref-type="bibr">12</xref>], lignans originate from cinnamic acid derivatives, which are biochemically related to the metabolism of phenylalanine. In particular, according to the incorporation of oxygen within the pattern of cyclization, lignans can be divided into eight subclasses [<xref rid="B3-molecules-25-05709" ref-type="bibr">3</xref>], namely dibenzylbutyrolactol, dibenzocyclooctadiene, dibenzylbutyrolactone, dibenzylbutane, arylnaphthalene, aryltetralin, furan, and furofuran lignans. The nutritional significance of lignans is unknown. Although lignans are not classified as dietary fibers, they share some of the chemical characteristics of lignin (a large plant polymer characterizing the cell wall), which is an insoluble fiber. Overall, the comprehensive database about the phenolic composition of foods, namely, Phenol-Explorer, reports 53 lignans (including both parent compounds and large intestine metabolites). In this regard, the plant lignans most commonly distributed in foods are reported to be lariciresinol, matairesinol, pinoresinol, and secoisolariciresinol. Several other lignans characterize plant foods, including medioresinol (such as sesame seeds, rye, and lemons), syringaresinol (in grains), sesamin, and the lignan precursor sesamolin (in sesame seeds). Other lignans found in foods but not often quantified include arctigenin, cyclolariciresinol (isolariciresinol), 7&#x02032;-hydroxymatairesinol, and 7-hydroxysecoisolariciresinol. Some cyclolariciresinol occurs naturally and a part arises from lariciresinol during extraction and analysis under acidic conditions. The most common lignan structures and major food sources are presented in <xref rid="molecules-25-05709-t001" ref-type="table">Table 1</xref>.</p><p>Starting from the previous considerations, the present review attempts to describe the potential beneficial effects of lignan intake as related to the modulation of gut microbiota and the possible interactions existing with the so-called &#x0201c;gut&#x02013;brain&#x0201d; axis. The latter represent a novel topic worthy to be investigated, considering that increasing evidence suggests that food ingested polyphenols can have beneficial effects in neuronal protection, acting against oxidative stress and inflammatory injury.</p></sec><sec id="sec2-molecules-25-05709"><title>2. Bioaccessibility and Bioavailability of Lignans during Gastrointestinal Digestion and Fermentation Process</title><p>The digestion process encompasses concatenated steps, each of them with particular physiological conditions to facilitate the release of food components to the lumen for subsequent intestinal absorption and distribution to organs and tissues.</p><p>Under in vitro simulated conditions of the stomach and small intestine, it was observed that release of secoisolariciresinol diglucoside (SDG) from the food digesta depends on the matrix characteristics with no release of secoisolariciresinol (SECO), thus suggesting marginal alteration of lignans during gastric and intestinal steps [<xref rid="B10-molecules-25-05709" ref-type="bibr">10</xref>]. Nevertheless, deglycosylation of SDG may occur via the action of brush border enzymes as suggested by the in vivo appearance of SECO in biofluids after the intake of SDG-rich source [<xref rid="B11-molecules-25-05709" ref-type="bibr">11</xref>,<xref rid="B12-molecules-25-05709" ref-type="bibr">12</xref>,<xref rid="B13-molecules-25-05709" ref-type="bibr">13</xref>]. However, the relation among ingested plant lignans and small intestinal-absorbed aglycones is low [<xref rid="B14-molecules-25-05709" ref-type="bibr">14</xref>], with a significant proportion reaching the colon for further processing by the local microbiota to produce the enterolignans enterodiol (ED) and enterolactone (EL). Overall, the gut microbial metabolism can be studied through in vitro and in vivo approaches. The most common procedure for in vitro fermentations consists in exposing the plant lignans source to fecal gut microbiota from either human or animal origin. This allows determining the sequence of bacterial reactions involved in the microbial catabolism of lignan precursors by analyzing samples collected at different time points [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>]. On the other hand, in vivo studies including dietary interventions (animals or humans) and epidemiological studies are pivotal to know the pharmacokinetic and bioavailability of colonic metabolites and their possible connection with biological activity [<xref rid="B9-molecules-25-05709" ref-type="bibr">9</xref>,<xref rid="B11-molecules-25-05709" ref-type="bibr">11</xref>,<xref rid="B13-molecules-25-05709" ref-type="bibr">13</xref>].</p><p>As exposed previously, the mammalian enterolignans ED and EL are the common major microbial end metabolites of plant lignans [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>,<xref rid="B16-molecules-25-05709" ref-type="bibr">16</xref>]. Hence, the colonic pathways of plant lignans can be almost wholly described taking as the starting point the parent compound further transformed to simpler compounds to conclude in the generation of ED and EL as promoted by microbial phase I reactions [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>,<xref rid="B16-molecules-25-05709" ref-type="bibr">16</xref>,<xref rid="B17-molecules-25-05709" ref-type="bibr">17</xref>]. An overview of the proposed colonic transformation pathway of plant lignans is reported in <xref ref-type="fig" rid="molecules-25-05709-f001">Figure 1</xref>.</p><p>Overall, pinoresinol diglucoside (PDG) undergoes two sequential deglycosylations to initially produce pinoresinol (PINO) monoglycoside and then PINO aglycone, which is converted to lariciresinol (LAR) by means of reduction reactions [<xref rid="B18-molecules-25-05709" ref-type="bibr">18</xref>]. Demethylation of LAR produces demethyl-LAR, which by subsequent reduction generates dimethyl-SECO; nevertheless, this route has been observed to possess little relevance [<xref rid="B18-molecules-25-05709" ref-type="bibr">18</xref>]. Alternatively, the reduction of LAR produces SECO that it can also be originated by deglycosylation of non-absorbed dietary SDG [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>]. In addition, LAR and SECO were identified in the urine of rats received a daily oral gavage of 15 mg of sesamin/kg b.w. during 10 d indicating they can also be originated by consecutive bacteria demethylation and dehydroxylation of sesamin [<xref rid="B19-molecules-25-05709" ref-type="bibr">19</xref>].</p><p>In view of the above, the final and decisive stages of the gut metabolism of many of the most common plant lignans can be described by bacterial transformations of SECO. The analysis of available data from in vitro and in vivo studies allows us to construct a detailed description of the colonic fate of SECO. In this regard, luminal SECO can be originated by microbial metabolism of plant lignans precursors or by non-absorbed SDG. Additionally, as reported by several in vitro studies, SDG is converted to SECO after two successive deglycosylations, leading to the transient appearance of SECO monoglycoside (SMG) [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>,<xref rid="B17-molecules-25-05709" ref-type="bibr">17</xref>]. Deglycosylation was observed to be a common property of a wide range of gut bacteria but specified consortia have the capability to continue metabolizing SECO [<xref rid="B16-molecules-25-05709" ref-type="bibr">16</xref>,<xref rid="B19-molecules-25-05709" ref-type="bibr">19</xref>]. Accordingly, a total of 17 metabolites, including intermediates (i.e., ED and EL), have been related to the colonic metabolism of SECO [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>,<xref rid="B17-molecules-25-05709" ref-type="bibr">17</xref>]. Initial demethylation of SECO generates demethyl-SECO from which demethyl-dehydroxy-SECO, didemethyl-SECO (dihydroxy-ED), didemethyl-dehydroxy-SECO (hydroxy-ED), and ED are generated by a combination of demethylation and dihydroxylation reactions [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>]. It was proposed that the demethylation of SECO should activate subsequent SECO modifications [<xref rid="B20-molecules-25-05709" ref-type="bibr">20</xref>]. An important metabolic step is the oxidation of ED, after which EL is generated. Another described route for the production of EL involves the generation of MAT after dehydrogenation of SECO. Nevertheless, MAT not always was successfully detected as an intermediate product of SECO [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>,<xref rid="B17-molecules-25-05709" ref-type="bibr">17</xref>] but the appearance of related derivatives as intermediates did not reject this hypothesis. These lactones derivatives have been described as demethyl-MAT, demethyl-dehydroxy-MAT, didemethyl-MAT (dihydroxy-EL), and didemethyl-dehydroxy-MAT (hydroxy-EL) although a second alternative for the generation of these metabolites was associated with dehydrogenation of the metabolites described previously [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>,<xref rid="B18-molecules-25-05709" ref-type="bibr">18</xref>]. On the other hand, both MAT and hydroxy-MAT (HMAT) are provided by several food products, making them an important dietary source of EL and hydroxy-EL precursors. In the colonic pathway of SECO cyclic ethers derivatives were also described, in which the first reaction involved in the appearance of anhydrosecoisolariciresinol (AHS) remains still to be clarified [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>]. The anhydrous metabolites were described after the in vitro fermentation of SDG [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>] and synthetically obtained AHS [<xref rid="B21-molecules-25-05709" ref-type="bibr">21</xref>] and include demethyl-anhydro SECO, didemethyl-anhydro SECO, and didemethyl-dehydroxy-anhydro concluding with the possible formation of enterofuran [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>,<xref rid="B21-molecules-25-05709" ref-type="bibr">21</xref>]. The colonic conversion of plant lignans into each other and the identification of some of the above-described intermediate metabolites were also observed in urine, plasma and/or feces after acute or sustained intake of dietary lignans in humans [<xref rid="B9-molecules-25-05709" ref-type="bibr">9</xref>,<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>] and animals [<xref rid="B21-molecules-25-05709" ref-type="bibr">21</xref>], which validate in vitro fermentation models to study the colonic fate of plant lignans.</p></sec><sec id="sec3-molecules-25-05709"><title>3. Intraindividual and Interindividual Variability in the Conversion of Plant Lignans</title><p>In an attempt to explore the gut transformation of plant lignans into enterolignans, both intraindividual and interindividual differences in the conversion rate, maximal yield, and pattern profile need to be carefully considered. Diverse intraindividual metabolic capacities are mainly associated with the chemical structure of the precursor and/or the matrix characteristics of the plant lignan source. However, exactly defining the effectiveness of such conversion, according to the type of lignan molecule, is a difficult task due to the inconsistency of results. Nonetheless, both in vitro [<xref rid="B19-molecules-25-05709" ref-type="bibr">19</xref>,<xref rid="B22-molecules-25-05709" ref-type="bibr">22</xref>] and in vivo [<xref rid="B23-molecules-25-05709" ref-type="bibr">23</xref>] studies reported that the catabolic transformation of SECO and MAT was observed to be greater than LAR, SYR, PINO, and sesamin and, in turn, that aglycones are more efficiently metabolized than diglucosylated derivatives. Except for MAT that generates EL but not ED, the contribution of each plant lignan to the whole pool of ED and EL is not entirely clear [<xref rid="B19-molecules-25-05709" ref-type="bibr">19</xref>]. Smeds et al. [<xref rid="B24-molecules-25-05709" ref-type="bibr">24</xref>] have observed that after a sustained oral dose of SECO and LAR to rats for 10 d, the ED:EL ratio decreased compared with the first single dose indicating that probably an adaptation of gut microbiota occurs during the dosage period toward a major efficiency to convert EL from ED. Nevertheless, the ED:EL ratio seems to be more closely associated with gut microbiota activity than the lignan molecule. Furthermore, the role of the food matrix and the origin source of plant lignan should not be underestimated since they may also explain differences, particularly in the production yield of enterolignans [<xref rid="B10-molecules-25-05709" ref-type="bibr">10</xref>].</p><p>Wide interindividual variability in the magnitude range and profile of enterolactones is a common observation in experimental and observational studies. Idiosyncrasy explains part of the individual physiological responses, but other aspects could contribute to understanding these deviations. Dietary interventions in which plant lignan-rich products were provided in a single [<xref rid="B11-molecules-25-05709" ref-type="bibr">11</xref>] or sustained dose [<xref rid="B9-molecules-25-05709" ref-type="bibr">9</xref>,<xref rid="B24-molecules-25-05709" ref-type="bibr">24</xref>,<xref rid="B25-molecules-25-05709" ref-type="bibr">25</xref>,<xref rid="B26-molecules-25-05709" ref-type="bibr">26</xref>] result in an evident increase of excreted and circulating levels of enterolignans. Observational studies also support these findings since variable amounts of enterolignans were quantified in the urine of healthy women (0.52, 1.95, and 6.22 ug/mg creatinine for low, middle, and high enterolactone excreters, respectively) [<xref rid="B5-molecules-25-05709" ref-type="bibr">5</xref>] and men (1.57 and 5.96 &#x000b5;mol/24 h for low and high enterolactone excreters, respectively) [<xref rid="B27-molecules-25-05709" ref-type="bibr">27</xref>] and in plasma of endoscopy individuals (4.5, 15.2, and 40.1 nmol/L for low, middle, and high enterolactone producers, respectively) [<xref rid="B28-molecules-25-05709" ref-type="bibr">28</xref>] and, in both cases, the highest tertile corresponded with those volunteers who reported major intake of plant lignans-rich food in habitual diet, especially dietary fiber.</p><p>Along with diet, the capacity of gut microbiota to metabolize non absorbed plant lignans determine the coexistence of different phenotypes: low, middle, and high enterolignan producers [<xref rid="B8-molecules-25-05709" ref-type="bibr">8</xref>,<xref rid="B9-molecules-25-05709" ref-type="bibr">9</xref>,<xref rid="B29-molecules-25-05709" ref-type="bibr">29</xref>], although other factors including genetics [<xref rid="B30-molecules-25-05709" ref-type="bibr">30</xref>], sex [<xref rid="B31-molecules-25-05709" ref-type="bibr">31</xref>], and age [<xref rid="B20-molecules-25-05709" ref-type="bibr">20</xref>,<xref rid="B32-molecules-25-05709" ref-type="bibr">32</xref>] could also contribute to metabolic differences. It was suggested that microbial dehydrogenation of ED to generate EL is a crucial step in the colon metabolism of plant lignans that could explain major variation in enterolignan production [<xref rid="B33-molecules-25-05709" ref-type="bibr">33</xref>]. The shift toward a major production of EL is desirable because this metabolite showed a stronger association with health benefits than ED [<xref rid="B34-molecules-25-05709" ref-type="bibr">34</xref>]. Eeckhaut et al. [<xref rid="B29-molecules-25-05709" ref-type="bibr">29</xref>] carried out an in vitro fermentation of flaxseed extract rich in SDG using feces from low and high enterolignan producers and observed that the later donor produced ten times more EL (200 nM) than the former (20 nM) whereas the amount of ED was similar in both batch cultures. This exciting finding was partially reproduced in humans after single or sustained supplementation of plant lignans. After the acute intake of SDG by healthy adults of both sexes, the cumulative excretion of ED and EL was 966 &#x000b1; 639 nmol/L&#x000b7;h for and 1762 &#x000b1; 1117 nmol/L&#x000b7;h, respectively. Among the participants, it was determined that EL was more than twice than ED in 5 out of 12 subjects, between 1 and 2 times in 5 out of 12 subjects and in 2 volunteers excreted ED was higher than EL [<xref rid="B31-molecules-25-05709" ref-type="bibr">31</xref>]. In another study, after the daily intake of 0.3 g flaxseed/kg body weight by healthy man for 1 week, the mean serum concentration of ED and EL increased 10-fold compared to baseline until reach 20 and 60 nM, respectively, but not all the participant responded to the same form since ED increased in all participants while EL remained unchanged in two subjects [<xref rid="B26-molecules-25-05709" ref-type="bibr">26</xref>]. Many dietary interventions including pharmacokinetic studies in human [<xref rid="B11-molecules-25-05709" ref-type="bibr">11</xref>] and animals [<xref rid="B23-molecules-25-05709" ref-type="bibr">23</xref>,<xref rid="B24-molecules-25-05709" ref-type="bibr">24</xref>] and prolonger plant lignan supplementation in human [<xref rid="B13-molecules-25-05709" ref-type="bibr">13</xref>] have presented the mean values of ED and EL or only EL in biofluids before and after the intervention. Still, they have not discriminated among categories of different metabolic responses losing the opportunity to gather data to define how individuals respond to plant lignans supplementation as proposed by other authors [<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>].</p><p>Overall, evidence that suggests that the production pattern of EL vary within age exists. For example, in an in vitro fermentation of the oilseed mix it was observed that the fecal microbiota from healthy young women generates more EL than those from premenopausal donors and this difference was attributed to diverse intestinal microbiota profile [<xref rid="B20-molecules-25-05709" ref-type="bibr">20</xref>]. This observation could explain a previous study in which a lower proportion of feces from postmenopausal women could generate EL compared with ED following in vitro fermentation of flaxseed extract [<xref rid="B35-molecules-25-05709" ref-type="bibr">35</xref>]. These results were not exactly reproduced under in vivo conditions. Postmenopausal women received an acute administration of 86 and 172 mg SDG showed major urinary EL (46.93 and 80.45 &#x000b5;mol/96 h for the low and high dose, respectively) than ED (29.78 and 46.3 &#x000b5;mol/96 h for the low and high dose, respectively). On the other hand, Milder et al. [<xref rid="B28-molecules-25-05709" ref-type="bibr">28</xref>] have observed an association between older volunteers and major circulating ED and EL. Nevertheless, the ED:EL ratio in urine was lower in younger than in older volunteers [<xref rid="B10-molecules-25-05709" ref-type="bibr">10</xref>]. In addition, the reduced plant lignans metabolic capacity is not only exclusive to old women, but also involves young children [<xref rid="B32-molecules-25-05709" ref-type="bibr">32</xref>] and man [<xref rid="B31-molecules-25-05709" ref-type="bibr">31</xref>]. Feces from children lower than 3 years-old inoculated with SECO generate dihydroxienterodiol but not ED and only 9 out of 24 fecal samples were able to generate EL, thus suggesting the presence of immature microbiota lacking in a bacteria population able to participate in some essential metabolic steps for the generation of mammalian enterolignans [<xref rid="B16-molecules-25-05709" ref-type="bibr">16</xref>]. The differences attributable to sex were noticed after a pharmacokinetic study where the plasma peak of EL appear earlier in women than men and the plasma concentration of EL and tended to be higher in women, but not differences were found in urine. Additionally, the differences attributable to sex were noticed during a pharmacokinetic study where EL peaked earlier and tended to be higher in women than men, although no significant differences were found in urine [<xref rid="B28-molecules-25-05709" ref-type="bibr">28</xref>].</p><p>In summary, alternative and simultaneous branches of metabolic pathways to transform non absorbed plant lignans into enterolignans do exist. These pathways are mainly defined by bacterial demethylation, reduction, dehydroxylation, and dehydrogenation; nevertheless, the main final metabolites are ED and EL. A comprehensive list of the most interesting studies can be observed in <xref rid="molecules-25-05709-t002" ref-type="table">Table 2</xref>. However, beside the intrinsic characteristics of individual lignan molecule, diet, and gut microbiota (conformation and activity) are dominant factors affecting the amount and profile of mammalian enterolactones produced in the colon. Therefore, in the context of plant lignans colon metabolism it was observed great interindividual differences, which has led to the identification of different phenotypes, which can be affected by age and sex, according to the capacity to produce enterolignan.</p></sec><sec><title>4. Modulation of Gut Microbiota by Enterolignans</title><p>Diet represents one of the main factors that can modulate the bacterial richness and abundance in the gastrointestinal tract of humans and animals [<xref rid="B42-molecules-25-05709" ref-type="bibr">42</xref>]. In this regard, the metabolites released by gut microbiota influence the physiological activities of the host [<xref rid="B43-molecules-25-05709" ref-type="bibr">43</xref>]. Furthermore, intestinal bacteria provide short chain fatty acids (SCFAs) and other metabolites as a result of diet component degradation [<xref rid="B44-molecules-25-05709" ref-type="bibr">44</xref>]. All these metabolites exert effects on both the host and other bacteria within the intestinal microbial community. They act as signaling molecules or as substrates for subsequent metabolic reactions. One of the most investigated fields of research is the fiber impact on gut microbiota metabolisms. In particular, plant-based diet rich in fiber have been linked to a <italic>Prevotella</italic> enterotype, whereas the <italic>Bacteroides</italic> enterotype was associated with a high intake of protein and fat [<xref rid="B45-molecules-25-05709" ref-type="bibr">45</xref>,<xref rid="B46-molecules-25-05709" ref-type="bibr">46</xref>]. Of particular interest are the results from an in vivo study, when considering the Hazda population and children from Burkina Faso [<xref rid="B47-molecules-25-05709" ref-type="bibr">47</xref>,<xref rid="B48-molecules-25-05709" ref-type="bibr">48</xref>]. In fact, the gut microbiota of Hazda population was enriched in <italic>Prevotella</italic>, <italic>Treponema,</italic> and an unclassified <italic>Bacteroidetes</italic>, while the diets of Burkina Faso children showed high abundance of <italic>Prevotella</italic> and <italic>Xylanibacter</italic> species. In both cases, diet was primarily plant-based and this favored groups of bacteria particularly efficient in degrading complex carbohydrates. The digestion of dietary fiber requires specific bacterial pathways due to the high content of complex polysaccharides and other compounds such as polyphenols, mainly tannins and lignans, which negatively affect their degradation. As widely discussed, polyphenols are usually classified into different subfamilies, according to their chemical structure. Their scaffolds represent the specific characteristic of the molecule and at the same time is the limiting factor for the production of possible final bioactive products. In fact, only some structures can be biotransformed by enzymes of both host and gut microbiota.</p><p>Regarding the transformation of lignans into enterolignans (i.e., enterodiols and enterolactones), despite the huge number of bacteria inhabiting gut microbiota, only few species have been identified as involved in such conversion [<xref rid="B20-molecules-25-05709" ref-type="bibr">20</xref>]. Besides, the enzymes responsible for this transformation remain unknown [<xref rid="B49-molecules-25-05709" ref-type="bibr">49</xref>]. Although mucosal enzymatic activities and chemical hydrolysis in the stomach may influence the bioavailability of lignans, the mechanisms underlying these processes are still under investigation. Indeed, controversial results are available in literature, since Clavel et al. [<xref rid="B50-molecules-25-05709" ref-type="bibr">50</xref>] reported that SDG was not hydrolyzed after prolonged incubation at 37 &#x000b0;C in artificial stomach juice (in vitro study). These results were in agreement with other similar experiments, including other lignans substrates [<xref rid="B51-molecules-25-05709" ref-type="bibr">51</xref>]. Thus, this data suggested that the bioavailability of SDG and other glycosylated lignans is not fully related to the hydrolysis promoted by the stomach juice, as normally described. Conversely, their bioavailability is strictly associated with gut microbiota metabolism. Hence, the role of gut microbiota in converting these compounds is very relevant since intestinal bacteria can turn some plant lignans such as sunflower, flaxseed, caraway, legumes, pumpkin, and soybean [<xref rid="B52-molecules-25-05709" ref-type="bibr">52</xref>], into mammalian lignans.</p><p>Several biochemical steps are involved in plant lignan transformation into enterolignans and the consortia of bacteria share metabolic intermediates. For example, bacteria utilize four sequential reactions to convert SDG to enterolactone (EL): O-deglycosylation, O-demethylation, dehydroxylation, and dehydrogenation [<xref rid="B53-molecules-25-05709" ref-type="bibr">53</xref>]. Despite the in vitro nature of the approach used, interesting conclusions concerning host-related metabolic capability were reported in literature. In fact, SDG was completely metabolized using human fecal microbiota, whereas the last step of this reaction did not occur when rat fecal inoculum was used. Of particular interest, a possible pathway involved in SDG metabolization was reported. This transformation was a cascade process that led to eight different compounds, corresponding to seven different enzymatic reactions. The role of enzymes in these conversions was confirmed by the absence of SDG degradation products in negative control without bacterial inoculum. Clavel et al. [<xref rid="B50-molecules-25-05709" ref-type="bibr">50</xref>] demonstrated that the first reaction involving the O-deglycosylase was closely related to the genera of <italic>Bacteroides</italic> and <italic>Clostridium</italic>. Among these, <italic>Clostridium cocleatum</italic>, <italic>Clostridium ramosum</italic>, <italic>Clostridium saccharogumia</italic>, <italic>Bacteroides distasonis</italic>, <italic>Bacteroides fragilis</italic>, and <italic>Bacteroides ovatus</italic> species have been demonstrated to catalyze this first reaction.</p><p>The second reaction in the conversion of SDG to EL is the O-demethylation of secoisolariciresinol (SECO) [<xref rid="B54-molecules-25-05709" ref-type="bibr">54</xref>] through the intermediate 2,3-bis-(3,4-dihydroxy-benzyl)butane-1,4-diol. <italic>Eubacterium limosum</italic> and <italic>Blautia producta</italic> and other bacteria are able to catalyze this conversion [<xref rid="B50-molecules-25-05709" ref-type="bibr">50</xref>,<xref rid="B53-molecules-25-05709" ref-type="bibr">53</xref>]. The O-demethylases proteins purified from strains of <italic>Eubacterium limosum</italic>, <italic>Moorella thermoacetica</italic>, <italic>Acetobacterium dehalogenans,</italic> and <italic>Desulfitobacterium hafniense</italic> have been investigated for their properties [<xref rid="B54-molecules-25-05709" ref-type="bibr">54</xref>,<xref rid="B55-molecules-25-05709" ref-type="bibr">55</xref>,<xref rid="B56-molecules-25-05709" ref-type="bibr">56</xref>,<xref rid="B57-molecules-25-05709" ref-type="bibr">57</xref>]. According to these studies, O-demethylase is composed of four components with a specific function and three of them are directly involved in the SECO conversion, whereas the fourth plays an accessory role. In fact, this protein reduces the corrinoid proteins, resulting by the enzymatic SECO conversion, thus reactivating them. Conversely, the other three enzymes are involved in a cascade process as described by Chen et al. [<xref rid="B58-molecules-25-05709" ref-type="bibr">58</xref>]. In particular, genes encoding for the first three components are organized in an operon, thus suggesting their simultaneous transcription, whereas the last one is separated from this locus. This indicates that the component responsible of the corrinoid protein reduction can act separately from the other three subunits, likely reactivating similar proteins in other enzymatic reactions [<xref rid="B58-molecules-25-05709" ref-type="bibr">58</xref>].</p><p>The third step is the dihydroxylation step to convert matairesinol into enterodiol (ED). ED is rapidly converted into EL via dehydrogenation. Consistent with this hypothesis, in a human trial, ED was detected only in five subjects out of 14, while EL was found in all individuals [<xref rid="B59-molecules-25-05709" ref-type="bibr">59</xref>].</p><p>Despite the information previously reported, no microorganisms have been identified that can completely metabolize the plant lignan SDG to EL. Thus, in a complex microbial community, cooperation between different groups of bacteria led to the production of EL. As an example, <italic>Eggerthella lenta</italic> is not able to directly convert SECO to EL, since it specifically converts an intermediate compound, the 2,3-bis-(3,4-dihydroxy-benzyl)butane-1,4-diol, to this final product. The entire conversion can be conducted by <italic>E. lenta</italic> when it is cocultured with <italic>Blautia producta</italic>. Indeed, this last species is able to produce the aforementioned intermediate that can be used as a substrate by <italic>E. lenta</italic>. We could speculate that such a relationship proved using an &#x0201c;in vitro&#x0201d; study could explain the production of EL also in the intestinal environment.</p><p>Concerning in vivo studies, little information is available in scientific literature. Of interest, in gnobiotic rats, the infection with <italic>Clostridium saccharogumia</italic>, <italic>E. lenta</italic>, <italic>B. producta</italic>, and <italic>Lactonifactor longoviformis</italic> and the administration of plant lignans SECO allow one to investigate the production of EL and ED. In the urine of these rats, ED and EL were detected, but not SECO. On the contrary, in the urine of not colonized animals, SECO was found but not its bioactive enterolignans [<xref rid="B60-molecules-25-05709" ref-type="bibr">60</xref>]. These observations confirm the role of bacteria in SECO conversion and the &#x0201c;in vitro&#x0201d; studies. In human, gut microbiome composition of young healthy (25&#x02013;30 years) and premenopausal women was assessed after incubation in batch in the presence of an oilseed mix. The ENL production increased in young women, whereas an increase of ED was detected in premenopausal subjects. Differences in <italic>Clostridiaceae</italic>, <italic>Klebsiella</italic> sp. and <italic>Collinsella</italic> sp. were observed. In particular, <italic>Clostridiaceae</italic> appeared higher in premenopausal volunteers than in the younger, thus suggesting the role of this family in lignans degradation.</p><p>Overall, it is important to highlight the in vitro nature of the most important findings in this field, thus representing a strong limitation when translated to in vivo applications. In fact, several data obtained did not consider the complexity of bacterial community and intestinal environment conditions. The conversion of lignans to enterolignans is influenced by many factors, such as pH, oxygen pressure, and temperature. On the other hand, these kinds of studies represent the best approach to investigate bacterial behavior without interference from host and other bacterial metabolisms. Therefore, many bacteria that are known to convert lignans into enterolignans have low abundance in the human intestine, thus making it difficult the study through an in vivo approach.</p></sec><sec id="sec5-molecules-25-05709"><title>5. Potential of Enterolignans as Health-Promoters and Modulators of the Gut&#x02013;Brain Axis</title><p>In the last years, several research works demonstrated that dietary polyphenols could have beneficial effects in cognitive functions, by acting against oxidative stress and inflammatory injury [<xref rid="B61-molecules-25-05709" ref-type="bibr">61</xref>,<xref rid="B62-molecules-25-05709" ref-type="bibr">62</xref>,<xref rid="B63-molecules-25-05709" ref-type="bibr">63</xref>]. Overall, biotransformation of polyphenols is a pivotal step to obtain metabolites active in brain, through a set of microbiota-related reactions occurring in the gut [<xref rid="B63-molecules-25-05709" ref-type="bibr">63</xref>]. In this regard, evidence suggests that polyphenols exert beneficial effects acting through multiple pathways involved in oxidative/inflammatory stress signaling and leading to the expression of antioxidant enzymes neurotrophic factors, and cytoprotective proteins. All these processes contribute to maintaining brain homeostasis [<xref rid="B64-molecules-25-05709" ref-type="bibr">64</xref>]. Epidemiological studies reported a strong protective effect of a lignan-rich diet towards cardiovascular diseases [<xref rid="B65-molecules-25-05709" ref-type="bibr">65</xref>]. The structural similarity between enterolignans and 17&#x003b2;-estradiol allows enterolignans to represent natural ligands of estrogen receptors [<xref rid="B66-molecules-25-05709" ref-type="bibr">66</xref>]. Consistently, a high lignan intake has been associated with beneficial effects on human health, due to reduced cardiovascular risk that involves the lowering of LDL cholesterol [<xref rid="B67-molecules-25-05709" ref-type="bibr">67</xref>] and the modulation of lipid metabolism [<xref rid="B68-molecules-25-05709" ref-type="bibr">68</xref>]. Despite showing pro-oxidant potential at high concentrations and in the presence of transition metal ions (like the other phenolics do), lignans have been also described as strong antioxidants via both a direct radical scavenging activity and an indirect enhancement of the activity of antioxidant enzymes [<xref rid="B69-molecules-25-05709" ref-type="bibr">69</xref>]. The enhanced antioxidant capacity imposed by lignans results in the regulation of key molecules involved in inflammation, resulting in the decrease of proinflammatory cytokines and mediators [<xref rid="B69-molecules-25-05709" ref-type="bibr">69</xref>].</p><p>It is known that oxidative stress is closely related to neuroinflammation phenomena, and that both processes are typically involved in neurodegenerative disorders. Phenolic compounds have been demonstrated to prevent neurological disorders through modulation of the gut&#x02013;brain axis [<xref rid="B70-molecules-25-05709" ref-type="bibr">70</xref>]. A recent study [<xref rid="B61-molecules-25-05709" ref-type="bibr">61</xref>] using different neuronal systems, reported that metabolites from dietary polyphenols exert neuroprotective effects after reaching the brain by crossing the blood&#x02013;brain barrier. Additionally, it was suggested that mammalian enterolignans play a prominent role, even higher than their precursors, against neurodegeneration [<xref rid="B71-molecules-25-05709" ref-type="bibr">71</xref>]. That is why considerable research effort was devoted to a complete understanding of the colonic transformations of plant lignans, leading to the generation of ED and EL, as explained in the previous sections. Polyphenols indirect actions involve mechanisms that improve the peripheral cerebrovascular health. Several studies in humans indicated that dietary polyphenols improve vasodilatory response and increase levels of circulating nitric oxide (NO) species that are essential in the control of vascular tone, vasodilation and blood flow in the body and in cerebral circulation [<xref rid="B72-molecules-25-05709" ref-type="bibr">72</xref>,<xref rid="B73-molecules-25-05709" ref-type="bibr">73</xref>].</p><p>Gut microbiota can interact with a central nervous system through different mechanisms and pathways, such as the neurosystems implicated in stress and stress-related disorders (sympathetic and parasympathetic branches of the autonomic nervous system and neuroendocrine and neuroimmune systems) [<xref rid="B74-molecules-25-05709" ref-type="bibr">74</xref>,<xref rid="B75-molecules-25-05709" ref-type="bibr">75</xref>,<xref rid="B76-molecules-25-05709" ref-type="bibr">76</xref>,<xref rid="B77-molecules-25-05709" ref-type="bibr">77</xref>]. The communication between these pathways occurs through the vagus nerve, specific metabolites, neurotransmitters, and brain neurotrophic factors [<xref rid="B78-molecules-25-05709" ref-type="bibr">78</xref>,<xref rid="B79-molecules-25-05709" ref-type="bibr">79</xref>,<xref rid="B80-molecules-25-05709" ref-type="bibr">80</xref>,<xref rid="B81-molecules-25-05709" ref-type="bibr">81</xref>]. Gut microbiota is able to synthetize neurotransmitters, and thus microbiota homeostasis can impact on complex neurodegenerative disorders. Examples are short-chain fatty acids (SCFAs), tryptophan, GABA, and a brain-derived neurotrophic factor (BDNF) [<xref rid="B82-molecules-25-05709" ref-type="bibr">82</xref>]. Specifically, the connection between gut microbiota and the central nervous system, the so-called gut&#x02013;brain axis, plays an important role in stress response and it is widely recognized as the neuroendocrine system [<xref rid="B83-molecules-25-05709" ref-type="bibr">83</xref>,<xref rid="B84-molecules-25-05709" ref-type="bibr">84</xref>,<xref rid="B85-molecules-25-05709" ref-type="bibr">85</xref>,<xref rid="B86-molecules-25-05709" ref-type="bibr">86</xref>,<xref rid="B87-molecules-25-05709" ref-type="bibr">87</xref>]. Communication between gut and brain involves multiple overlapping pathways: the enteric nervous system and the neuroimmune and the neuroendocrine systems [<xref rid="B88-molecules-25-05709" ref-type="bibr">88</xref>,<xref rid="B89-molecules-25-05709" ref-type="bibr">89</xref>]. By interacting with the nervous, endocrine, and immune systems, gut microbiota can influence both directly and indirectly the brain functions. A schematic representation of the gut microbiota&#x02013;brain interaction when considering lignans and their metabolites is provided as <xref ref-type="fig" rid="molecules-25-05709-f002">Figure 2</xref>.</p><p>Overall, the microbiota directly influences the brain functions via the production of neurotransmitters and neuropeptides, in turn acting on neuroactive metabolites production [<xref rid="B90-molecules-25-05709" ref-type="bibr">90</xref>,<xref rid="B91-molecules-25-05709" ref-type="bibr">91</xref>,<xref rid="B92-molecules-25-05709" ref-type="bibr">92</xref>]. In fact, some of these neurotransmitters are able to cross the mucosal layer of the intestines, thus reaching the brain where they can mediate different physiological events [<xref rid="B93-molecules-25-05709" ref-type="bibr">93</xref>]. Alteration in the homeostasis of gut&#x02013;brain axis has been associated also to neurological disorders and neurodegenerative diseases [<xref rid="B94-molecules-25-05709" ref-type="bibr">94</xref>]. Moreover, it is emerging that the regulation of microbiota composition can be realized using natural bioactive molecules such as polyphenols derived by plants, suggesting that polyphenols could be used to restore the altered brain functions that characterize neurodegenerative diseases.</p><p>Flaxseed-derived lignans, secoisolariciresinol diglucoside (SDG) and pinoresinol diglucoside, are metabolized by the intestinal bacteria, <italic>Ruminococcus</italic> species, in humans, to give the enterolignans (+)-dihydroxyenterodiol and (+)-enterolactone [<xref rid="B95-molecules-25-05709" ref-type="bibr">95</xref>,<xref rid="B96-molecules-25-05709" ref-type="bibr">96</xref>]. This gut bacterial species accomplishes both deglycosylation and demethylation of plant-based lignans to give human lignans that are of broad physiological effects. Enterolactone has been related to anticancer activity [<xref rid="B97-molecules-25-05709" ref-type="bibr">97</xref>,<xref rid="B98-molecules-25-05709" ref-type="bibr">98</xref>]. For example, it was shown that enterolactone inhibits the growth of prostate cancer cell lines in vitro and in vivo, through a caspase-dependent pathway [<xref rid="B99-molecules-25-05709" ref-type="bibr">99</xref>]. Enterolactone and secoisolariciresinol are inhibitors of carbonic anhydrase [<xref rid="B100-molecules-25-05709" ref-type="bibr">100</xref>] and acetylcholinesterase and butyrylcholinesterase, and thus may afford neuroprotection [<xref rid="B101-molecules-25-05709" ref-type="bibr">101</xref>]. In this regard, Alzheimer&#x02019;s disease (AD) patients show lower levels of acetylcholine in the neuronal synapses, thus leading to the memory loss phenomena. Therefore, through the inhibition of the acetylcholinesterase, these lignans may prevent memory loss in AD patients, hence providing a nutritional strategy to complement the use of synthetically derived acetylcholinesterase inhibitors. In fact, the available commercial pharmaceuticals (i.e., donepezil, galantamine, and rivastigmine) only show a symptomatic relief, whereas lignans may, in addition, help in attenuating the progress of AD [<xref rid="B102-molecules-25-05709" ref-type="bibr">102</xref>]. As a further example, the gut bacterial metabolite enterolactone, formed through intestinal bacterial metabolism of the lignan 7-hydroxymatairesinol (HMR), was found to attenuate the degeneration of the striatal dopaminergic terminals in Parkinson&#x02019;s disease (PD), in the PD rat models [<xref rid="B103-molecules-25-05709" ref-type="bibr">103</xref>].</p><p>Therefore, dietary polyphenolic compounds are potentially able to affect the gut&#x02013;brain axis via modulation of the gut microbiota, and thus may be used as nutraceuticals in the prevention of neurological disorders. However, with this regard, it is important to bear in mind that the role of gut microbiota in the health outcomes of dietary (poly)phenols is of paramount importance [<xref rid="B104-molecules-25-05709" ref-type="bibr">104</xref>].</p></sec><sec sec-type="conclusions" id="sec6-molecules-25-05709"><title>6. Conclusions and Future Perspectives</title><p>Polyphenols may be useful for chronic intestinal disorders, acting at the intestinal level where they achieve their highest concentration in the human body, interacting with inflammation-related cellular signaling pathways and modulating gut microbiota. Furthermore, they can also provide an interesting strategy to defeat neurological disorders, either by direct mechanisms, involving the reduction of neuroinflammation and the enhancement of memory and cognitive functions, or by indirect mechanisms, implying the modulation of gut microbiota and the reduction of intestinal inflammation. Interestingly, native lignans, despite exerting health benefits in the gastrointestinal tract, are substrates for gut microbiota-derived metabolites that are involved in the systemic effects attributed to their parental compounds. Dietary lignans and their gut metabolites should, therefore, be considered as promising nutraceuticals for preventing chronic disorders. In particular, the regulation of gut microbiota composition using polyphenols (such as lignans) may help to restore gut equilibrium and to set up new therapeutic intervention in neuropathologies. In fact, since brain dysfunctions can be linked with dysbiosis of the gut microbiota, a rebalance in the gut microbiota composition may result in a partial or complete reversion of the diseases. Finally, regarding future research directions, a better understanding of the interplay existing between lignans (mainly when considering the gut metabolites enterolignans) and gut microbiota will provide more insight into their health effects, thus opening new possibilities to develop microbiota-based therapies for treating neuronal disorders.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Each author contributed equally. Conceptualization: G.R. and L.L; original draft, and writing: A.S., G.R., J.I.M., M.L.C.; L.L.; images and tables, A.S., G.R., J.I.M., M.L.C.; review and editing, M.L.C., V.P., L.M., L.L. Each author contributed to revising critically the manuscript for important intellectual content. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-05709"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothwell</surname><given-names>J.A.</given-names></name><name><surname>Urpi-Sarda</surname><given-names>M.</given-names></name><name><surname>Boto-Ordo&#x000f1;ez</surname><given-names>M.</given-names></name><name><surname>Llorach</surname><given-names>R.</given-names></name><name><surname>Farran-Codina</surname><given-names>A.</given-names></name><name><surname>Barupal</surname><given-names>D.K.</given-names></name><name><surname>Neveu</surname><given-names>V.</given-names></name><name><surname>Manach</surname><given-names>C.</given-names></name><name><surname>Andres-Lacueva</surname><given-names>C.</given-names></name><name><surname>Scalbert</surname><given-names>A.</given-names></name></person-group><article-title>Systematic analysis of the polyphenol metabolome using the Phenol-Explorer database</article-title><source>Mol. Nutr. Food Res.</source><year>2015</year><volume>60</volume><fpage>203</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201500435</pub-id><?supplied-pmid 26310602?><pub-id pub-id-type="pmid">26310602</pub-id></element-citation></ref><ref id="B2-molecules-25-05709"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giuberti</surname><given-names>G.</given-names></name><name><surname>Rocchetti</surname><given-names>G.</given-names></name><name><surname>Lucini</surname><given-names>L.</given-names></name></person-group><article-title>Interactions between phenolic compounds, amylolytic enzymes and starch: An updated overview</article-title><source>Curr. Opin. Food Sci.</source><year>2020</year><volume>31</volume><fpage>102</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.cofs.2020.04.003</pub-id></element-citation></ref><ref id="B3-molecules-25-05709"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez-Garc&#x000ed;a</surname><given-names>C.</given-names></name><name><surname>S&#x000e1;nchez-Quesada</surname><given-names>C.</given-names></name><name><surname>Toledo</surname><given-names>E.</given-names></name><name><surname>Delgado-Rodr&#x000ed;guez</surname><given-names>M.</given-names></name><name><surname>Gaforio</surname><given-names>J.J.</given-names></name></person-group><article-title>Naturally lignan-rich foods: A dietary tool for health promotion?</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>917</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24050917</pub-id><?supplied-pmid 30845651?><pub-id pub-id-type="pmid">30845651</pub-id></element-citation></ref><ref id="B4-molecules-25-05709"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rietjens</surname><given-names>I.M.C.M.</given-names></name><name><surname>Louisse</surname><given-names>J.</given-names></name><name><surname>Beekmann</surname><given-names>K.</given-names></name></person-group><article-title>The potential health effects of dietary phytoestrogens</article-title><source>Br. J. Pharmacol.</source><year>2017</year><volume>174</volume><fpage>1263</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1111/bph.13622</pub-id><pub-id pub-id-type="pmid">27723080</pub-id></element-citation></ref><ref id="B5-molecules-25-05709"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaineddin</surname><given-names>A.K.</given-names></name><name><surname>Buck</surname><given-names>K.</given-names></name><name><surname>Vrieling</surname><given-names>A.</given-names></name><name><surname>Heinz</surname><given-names>J.</given-names></name><name><surname>Flesch-Janys</surname><given-names>D.</given-names></name><name><surname>Linseisen</surname><given-names>J.</given-names></name><name><surname>Chang-Claude</surname><given-names>J.</given-names></name></person-group><article-title>The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: A German case-control study</article-title><source>Nutr. Cancer</source><year>2012</year><volume>64</volume><fpage>652</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1080/01635581.2012.683227</pub-id><pub-id pub-id-type="pmid">22591208</pub-id></element-citation></ref><ref id="B6-molecules-25-05709"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>J.</given-names></name><name><surname>Dwyer</surname><given-names>J.</given-names></name><name><surname>Adlercreutz</surname><given-names>H.</given-names></name><name><surname>Scalbert</surname><given-names>A.</given-names></name><name><surname>Jacques</surname><given-names>P.</given-names></name><name><surname>McCullough</surname><given-names>M.L.</given-names></name></person-group><article-title>Dietary lignans: Physiology and potential for cardiovascular disease risk reduction</article-title><source>Nutr. Rev.</source><year>2010</year><volume>68</volume><fpage>571</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.2010.00319.x</pub-id><pub-id pub-id-type="pmid">20883417</pub-id></element-citation></ref><ref id="B7-molecules-25-05709"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothwell</surname><given-names>J.A.</given-names></name><name><surname>Perez-Jimenez</surname><given-names>J.</given-names></name><name><surname>Neveu</surname><given-names>V.</given-names></name><name><surname>Medina-Rem&#x000f3;n</surname><given-names>A.</given-names></name><name><surname>M&#x02019;Hiri</surname><given-names>N.</given-names></name><name><surname>Garc&#x000ed;a-Lobato</surname><given-names>P.</given-names></name><name><surname>Manach</surname><given-names>C.</given-names></name><name><surname>Knox</surname><given-names>C.</given-names></name><name><surname>Eisner</surname><given-names>R.</given-names></name><name><surname>Wishart</surname><given-names>D.S.</given-names></name><etal/></person-group><article-title>Phenol-Explorer 3.0: A major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content</article-title><source>Database</source><year>2013</year><volume>2013</volume><fpage>bat070</fpage><pub-id pub-id-type="doi">10.1093/database/bat070</pub-id><pub-id pub-id-type="pmid">24103452</pub-id></element-citation></ref><ref id="B8-molecules-25-05709"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landete</surname><given-names>J.M.</given-names></name></person-group><article-title>Plant and mammalian lignans: A review of source, intake, metabolism, intestinal bacteria and health</article-title><source>Food Res. Int.</source><year>2012</year><volume>46</volume><fpage>410</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2011.12.023</pub-id></element-citation></ref><ref id="B9-molecules-25-05709"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miles</surname><given-names>F.L.</given-names></name><name><surname>Navarro</surname><given-names>S.L.</given-names></name><name><surname>Schwarz</surname><given-names>Y.</given-names></name><name><surname>Gu</surname><given-names>H.</given-names></name><name><surname>Djukovic</surname><given-names>D.</given-names></name><name><surname>Randolph</surname><given-names>T.W.</given-names></name><name><surname>Shojaie</surname><given-names>A.</given-names></name><name><surname>Kratz</surname><given-names>M.</given-names></name><name><surname>Hullar</surname><given-names>M.A.J.</given-names></name><name><surname>Lampe</surname><given-names>P.D.</given-names></name><etal/></person-group><article-title>Plasma metabolite abundances are associated with urinary enterolactone excretion in healthy participants on controlled diets</article-title><source>Food Funct.</source><year>2017</year><volume>8</volume><fpage>3209</fpage><lpage>3218</lpage><pub-id pub-id-type="doi">10.1039/C7FO00684E</pub-id><pub-id pub-id-type="pmid">28808723</pub-id></element-citation></ref><ref id="B10-molecules-25-05709"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuentealba</surname><given-names>C.</given-names></name><name><surname>Figuerola</surname><given-names>F.</given-names></name><name><surname>Est&#x000e9;vez</surname><given-names>A.M.</given-names></name><name><surname>Basat&#x000ed;as</surname><given-names>J.M.</given-names></name><name><surname>Munoz</surname><given-names>O.</given-names></name></person-group><article-title>Bioaccessibility of lignans from flaxseed (<italic>Linum usitatissimum</italic> L.) determined by single-batch in vitro simulation of the digestive process</article-title><source>J. Sci. Food Agric.</source><year>2014</year><volume>94</volume><fpage>1729</fpage><lpage>1738</lpage><pub-id pub-id-type="doi">10.1002/jsfa.6482</pub-id><pub-id pub-id-type="pmid">24243589</pub-id></element-citation></ref><ref id="B11-molecules-25-05709"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setchell</surname><given-names>K.D.R.</given-names></name><name><surname>Brown</surname><given-names>N.M.</given-names></name><name><surname>Zimmer-Nechemias</surname><given-names>L.</given-names></name><name><surname>Wolfe</surname><given-names>B.</given-names></name><name><surname>Jha</surname><given-names>P.</given-names></name><name><surname>Heubi</surname><given-names>J.E.</given-names></name></person-group><article-title>Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans</article-title><source>Food Funct.</source><year>2014</year><volume>5</volume><fpage>491</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1039/C3FO60402K</pub-id><?supplied-pmid 24429845?><pub-id pub-id-type="pmid">24429845</pub-id></element-citation></ref><ref id="B12-molecules-25-05709"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teponno</surname><given-names>R.B.</given-names></name><name><surname>Kusari</surname><given-names>S.</given-names></name><name><surname>Spiteller</surname><given-names>M.</given-names></name></person-group><article-title>Recent advances in research on lignans and neolignans</article-title><source>Nat. Prod. Rep.</source><year>2016</year><volume>33</volume><fpage>1044</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1039/C6NP00021E</pub-id><?supplied-pmid 27157413?><pub-id pub-id-type="pmid">27157413</pub-id></element-citation></ref><ref id="B13-molecules-25-05709"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>Y.</given-names></name><name><surname>Jones</surname><given-names>J.</given-names></name><name><surname>Mansell</surname><given-names>K.</given-names></name><name><surname>Whiting</surname><given-names>S.</given-names></name><name><surname>Fowler</surname><given-names>S.</given-names></name><name><surname>Thorpe</surname><given-names>L.</given-names></name><name><surname>Billinsky</surname><given-names>J.</given-names></name><name><surname>Viveky</surname><given-names>N.</given-names></name><name><surname>Cheng</surname><given-names>P.C.</given-names></name><name><surname>Almousa</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Influence of flaxseed lignan supplementation to older adults on biochemical and functional outcome measures of inflammation</article-title><source>J. Am. Coll. Nutr.</source><year>2017</year><volume>36</volume><fpage>646</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1080/07315724.2017.1342213</pub-id><?supplied-pmid 28922068?><pub-id pub-id-type="pmid">28922068</pub-id></element-citation></ref><ref id="B14-molecules-25-05709"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolvig</surname><given-names>A.K.</given-names></name><name><surname>Adlercreutz</surname><given-names>H.</given-names></name><name><surname>Theil</surname><given-names>P.K.</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>H.</given-names></name><name><surname>Knudsen</surname><given-names>K.E.B.</given-names></name></person-group><article-title>Absorption of plant lignans from cereals in an experimental pig model</article-title><source>Br. J. Nutr.</source><year>2016</year><volume>115</volume><fpage>1711</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1017/S0007114516000829</pub-id><pub-id pub-id-type="pmid">27001342</pub-id></element-citation></ref><ref id="B15-molecules-25-05709"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quartieri</surname><given-names>A.</given-names></name><name><surname>Garc&#x000ed;a-Villalba</surname><given-names>R.</given-names></name><name><surname>Amaretti</surname><given-names>A.</given-names></name><name><surname>Raimondi</surname><given-names>S.</given-names></name><name><surname>Leonardi</surname><given-names>A.</given-names></name><name><surname>Rossi</surname><given-names>M.</given-names></name><name><surname>Tom&#x000e0;s-Barber&#x000e0;n</surname><given-names>F.</given-names></name></person-group><article-title>Detection of novel metabolites of flaxseed lignans in vitro and in vivo</article-title><source>Mol. Nutr. Food Res.</source><year>2016</year><volume>60</volume><fpage>1590</fpage><lpage>1601</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201500773</pub-id><pub-id pub-id-type="pmid">26873880</pub-id></element-citation></ref><ref id="B16-molecules-25-05709"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaya</surname><given-names>P.</given-names></name><name><surname>Peirot&#x000e9;n</surname><given-names>&#x000c1;.</given-names></name><name><surname>Medina</surname><given-names>M.</given-names></name><name><surname>Landete</surname><given-names>J.M.</given-names></name></person-group><article-title>Bifidobacterium adolescentis INIA P784: The first probiotic bacterium capable of producing enterodiol from lignan extracts</article-title><source>J. Funct. Foods</source><year>2017</year><volume>29</volume><fpage>269</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2016.12.044</pub-id></element-citation></ref><ref id="B17-molecules-25-05709"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peirot&#x000e9;n</surname><given-names>&#x000c1;.</given-names></name><name><surname>Gaya</surname><given-names>P.</given-names></name><name><surname>&#x000c1;lvarez</surname><given-names>I.</given-names></name><name><surname>Bravo</surname><given-names>D.</given-names></name><name><surname>Landete</surname><given-names>J.M.</given-names></name></person-group><article-title>Influence of different lignan compounds on enterolignan production by <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic> strains</article-title><source>Int. J. Food Microbiol.</source><year>2019</year><volume>289</volume><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2018.08.028</pub-id><pub-id pub-id-type="pmid">30193121</pub-id></element-citation></ref><ref id="B18-molecules-25-05709"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosele</surname><given-names>J.I.</given-names></name><name><surname>Maci&#x000e0;</surname><given-names>A.</given-names></name><name><surname>Motilva</surname><given-names>M.-J.</given-names></name></person-group><article-title>Metabolic and microbial modulation of the large intestine ecosystem by non-absorbed diet phenolic compounds: A review</article-title><source>Molecules</source><year>2015</year><volume>20</volume><fpage>17429</fpage><lpage>17468</lpage><pub-id pub-id-type="doi">10.3390/molecules200917429</pub-id><pub-id pub-id-type="pmid">26393570</pub-id></element-citation></ref><ref id="B19-molecules-25-05709"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Saarinen</surname><given-names>N.M.</given-names></name><name><surname>Thompson</surname><given-names>L.U.</given-names></name></person-group><article-title>Sesamin is one of the major precursors of mammalian lignans in sesame seed (<italic>Sesamum indicum</italic>) as observed in vitro and in rats</article-title><source>J. Nutr.</source><year>2006</year><volume>136</volume><fpage>906</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1093/jn/136.4.906</pub-id><pub-id pub-id-type="pmid">16549449</pub-id></element-citation></ref><ref id="B20-molecules-25-05709"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corona</surname><given-names>G.</given-names></name><name><surname>Kreimes</surname><given-names>A.</given-names></name><name><surname>Barone</surname><given-names>M.</given-names></name><name><surname>Turroni</surname><given-names>S.</given-names></name><name><surname>Brigidi</surname><given-names>P.</given-names></name><name><surname>Keleszade</surname><given-names>E.</given-names></name><name><surname>Costabile</surname><given-names>A.</given-names></name></person-group><article-title>Impact of lignans in oilseed mix on gut microbiome composition and enterolignan production in younger healthy and premenopausal women: An in vitro pilot study</article-title><source>Microb. Cell Factories</source><year>2020</year><volume>19</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/s12934-020-01341-0</pub-id></element-citation></ref><ref id="B21-molecules-25-05709"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Struijs</surname><given-names>K.</given-names></name><name><surname>Vincken</surname><given-names>J.-P.</given-names></name><name><surname>Gruppen</surname><given-names>H.</given-names></name></person-group><article-title>Bacterial conversion of secoisolariciresinol and anhydrosecoisolariciresinol</article-title><source>J. Appl. Microbiol.</source><year>2009</year><volume>107</volume><fpage>308</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2009.04209.x</pub-id><?supplied-pmid 19302311?><pub-id pub-id-type="pmid">19302311</pub-id></element-citation></ref><ref id="B22-molecules-25-05709"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kezimana</surname><given-names>P.</given-names></name><name><surname>Dmitriev</surname><given-names>A.A.</given-names></name><name><surname>Kudryavtseva</surname><given-names>A.V.</given-names></name><name><surname>Romanova</surname><given-names>E.V.</given-names></name><name><surname>Melnikova</surname><given-names>N.V.</given-names></name></person-group><article-title>Secoisolariciresinol diglucoside of flaxseed and its metabolites: Biosynthesis and potential for nutraceuticals</article-title><source>Front. Genet.</source><year>2018</year><volume>9</volume><fpage>641</fpage><pub-id pub-id-type="doi">10.3389/fgene.2018.00641</pub-id><?supplied-pmid 30619466?><pub-id pub-id-type="pmid">30619466</pub-id></element-citation></ref><ref id="B23-molecules-25-05709"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>H.-J.</given-names></name><name><surname>Wei</surname><given-names>Z.-Y.</given-names></name><name><surname>Lu</surname><given-names>P.-C.</given-names></name><name><surname>Huang</surname><given-names>P.-L.</given-names></name><name><surname>Lee</surname><given-names>K.-T.</given-names></name></person-group><article-title>Bioconversion of pinoresinol into matairesinol by use of recombinant <italic>Escherichia coli</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2014</year><volume>80</volume><fpage>2687</fpage><lpage>2692</lpage><pub-id pub-id-type="doi">10.1128/AEM.03397-13</pub-id><?supplied-pmid 24561584?><pub-id pub-id-type="pmid">24561584</pub-id></element-citation></ref><ref id="B24-molecules-25-05709"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smeds</surname><given-names>A.</given-names></name><name><surname>Saarinen</surname><given-names>N.M.</given-names></name><name><surname>Hurmerinta</surname><given-names>T.T.</given-names></name><name><surname>Penttinen</surname><given-names>P.E.</given-names></name><name><surname>Sj&#x000f6;holm</surname><given-names>R.E.</given-names></name><name><surname>M&#x000e4;kel&#x000e4;</surname><given-names>S.I.</given-names></name></person-group><article-title>Urinary excretion of lignans after administration of isolated plant lignans to rats: The effect of single dose and ten-day exposures</article-title><source>J. Chromatogr. B</source><year>2004</year><volume>813</volume><fpage>303</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.jchromb.2004.10.033</pub-id><?supplied-pmid 15556546?><pub-id pub-id-type="pmid">15556546</pub-id></element-citation></ref><ref id="B25-molecules-25-05709"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000e6;rke</surname><given-names>H.N.</given-names></name><name><surname>Mortensen</surname><given-names>M.A.</given-names></name><name><surname>Hedemann</surname><given-names>M.S.</given-names></name><name><surname>Knudsen</surname><given-names>K.E.B.</given-names></name><name><surname>Penalvo</surname><given-names>J.L.</given-names></name><name><surname>Adlercreutz</surname><given-names>H.</given-names></name></person-group><article-title>Quantitative aspects of the metabolism of lignans in pigs fed fibre-enriched rye and wheat bread</article-title><source>Br. J. Nutr.</source><year>2009</year><volume>102</volume><fpage>985</fpage><lpage>994</lpage><pub-id pub-id-type="doi">10.1017/S0007114509344098</pub-id><?supplied-pmid 19393112?><pub-id pub-id-type="pmid">19393112</pub-id></element-citation></ref><ref id="B26-molecules-25-05709"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagkouvardos</surname><given-names>I.</given-names></name><name><surname>Kl&#x000e4;ring</surname><given-names>K.</given-names></name><name><surname>Heinzmann</surname><given-names>S.S.</given-names></name><name><surname>Platz</surname><given-names>S.</given-names></name><name><surname>Scholz</surname><given-names>B.</given-names></name><name><surname>Engel</surname><given-names>K.-H.</given-names></name><name><surname>Schmitt-Kopplin</surname><given-names>P.</given-names></name><name><surname>Haller</surname><given-names>D.</given-names></name><name><surname>Rohn</surname><given-names>S.</given-names></name><name><surname>Skurk</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Gut metabolites and bacterial community networks during a pilot intervention study with flaxseeds in healthy adult men</article-title><source>Mol. Nutr. Food Res.</source><year>2015</year><volume>59</volume><fpage>1614</fpage><lpage>1628</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201500125</pub-id><pub-id pub-id-type="pmid">25988339</pub-id></element-citation></ref><ref id="B27-molecules-25-05709"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurmi</surname><given-names>T.</given-names></name><name><surname>Mursu</surname><given-names>J.</given-names></name><name><surname>Pe&#x000f1;alvo</surname><given-names>J.L.</given-names></name><name><surname>Poulsen</surname><given-names>H.E.</given-names></name><name><surname>Voutilainen</surname><given-names>S.</given-names></name></person-group><article-title>Dietary intake and urinary excretion of lignans in Finnish men</article-title><source>Br. J. Nutr.</source><year>2010</year><volume>103</volume><fpage>677</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1017/S0007114509992261</pub-id><pub-id pub-id-type="pmid">19811696</pub-id></element-citation></ref><ref id="B28-molecules-25-05709"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milder</surname><given-names>I.E.J.</given-names></name><name><surname>Kuijsten</surname><given-names>A.</given-names></name><name><surname>Arts</surname><given-names>I.C.W.</given-names></name><name><surname>Feskens</surname><given-names>E.J.M.</given-names></name><name><surname>Kampman</surname><given-names>E.</given-names></name><name><surname>Hollman</surname><given-names>P.C.H.</given-names></name><name><surname>Veer</surname><given-names>P.V.</given-names></name></person-group><article-title>Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population</article-title><source>J. Nutr.</source><year>2007</year><volume>137</volume><fpage>1266</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.1093/jn/137.5.1266</pub-id><pub-id pub-id-type="pmid">17449591</pub-id></element-citation></ref><ref id="B29-molecules-25-05709"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eeckhaut</surname><given-names>E.</given-names></name><name><surname>Struijs</surname><given-names>K.</given-names></name><name><surname>Possemiers</surname><given-names>S.</given-names></name><name><surname>Vincken</surname><given-names>J.-P.</given-names></name><name><surname>De Keukeleire</surname><given-names>D.</given-names></name><name><surname>Verstraete</surname><given-names>W.</given-names></name></person-group><article-title>Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem</article-title><source>J. Agric. Food Chem.</source><year>2008</year><volume>56</volume><fpage>4806</fpage><lpage>4812</lpage><pub-id pub-id-type="doi">10.1021/jf800101s</pub-id><pub-id pub-id-type="pmid">18494490</pub-id></element-citation></ref><ref id="B30-molecules-25-05709"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H.</given-names></name><name><surname>Yao</surname><given-names>S.</given-names></name><name><surname>Tritchler</surname><given-names>D.</given-names></name><name><surname>Hullar</surname><given-names>M.A.</given-names></name><name><surname>Lampe</surname><given-names>J.W.</given-names></name><name><surname>Thompson</surname><given-names>L.U.</given-names></name><name><surname>McCann</surname><given-names>S.E.</given-names></name></person-group><article-title>Genetic variation in steroid and xenobiotic metabolizing pathways and enterolactone excretion before and after flaxseed intervention in African American and European American women</article-title><source>Cancer Epidemiol. Biomarkers Prev.</source><year>2019</year><volume>28</volume><fpage>265</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-18-0826</pub-id><pub-id pub-id-type="pmid">30709839</pub-id></element-citation></ref><ref id="B31-molecules-25-05709"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuijsten</surname><given-names>A.</given-names></name><name><surname>Arts</surname><given-names>I.C.W.</given-names></name><name><surname>Veer</surname><given-names>P.V.</given-names></name><name><surname>Hollman</surname><given-names>P.C.H.</given-names></name></person-group><article-title>The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed</article-title><source>J. Nutr.</source><year>2005</year><volume>135</volume><fpage>2812</fpage><lpage>2816</lpage><pub-id pub-id-type="doi">10.1093/jn/135.12.2812</pub-id><?supplied-pmid 16317125?><pub-id pub-id-type="pmid">16317125</pub-id></element-citation></ref><ref id="B32-molecules-25-05709"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000e5;lldin</surname><given-names>E.</given-names></name><name><surname>Eriksen</surname><given-names>A.K.</given-names></name><name><surname>Brunius</surname><given-names>C.</given-names></name><name><surname>Da Silva</surname><given-names>A.B.</given-names></name><name><surname>Bronze</surname><given-names>M.</given-names></name><name><surname>Hanhineva</surname><given-names>K.</given-names></name><name><surname>Aura</surname><given-names>A.-M.</given-names></name><name><surname>Landberg</surname><given-names>R.</given-names></name></person-group><article-title>Factors explaining interpersonal variation in plasma enterolactone concentrations in humans</article-title><source>Mol. Nutr. Food Res.</source><year>2019</year><volume>63</volume><fpage>e1801159</fpage><pub-id pub-id-type="doi">10.1002/mnfr.201801159</pub-id><?supplied-pmid 30817848?><pub-id pub-id-type="pmid">30817848</pub-id></element-citation></ref><ref id="B33-molecules-25-05709"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>A.F.</given-names></name><name><surname>Zang</surname><given-names>Y.</given-names></name></person-group><article-title>A review of lignan metabolism, milk enterolactone concentration, and antioxidant status of dairy cows fed flaxseed</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>41</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24010041</pub-id></element-citation></ref><ref id="B34-molecules-25-05709"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>S.L.</given-names></name><name><surname>Kirk</surname><given-names>R.D.</given-names></name><name><surname>DaSilva</surname><given-names>N.A.</given-names></name><name><surname>Ma</surname><given-names>H.</given-names></name><name><surname>Seeram</surname><given-names>N.P.</given-names></name><name><surname>Bertin</surname><given-names>M.J.</given-names></name></person-group><article-title>Polyphenol microbial metabolites exhibit gut and blood&#x02013;brain barrier permeability and protect murine microglia against LPS-induced inflammation</article-title><source>Metabolites</source><year>2019</year><volume>9</volume><elocation-id>78</elocation-id><pub-id pub-id-type="doi">10.3390/metabo9040078</pub-id></element-citation></ref><ref id="B35-molecules-25-05709"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Possemiers</surname><given-names>S.</given-names></name><name><surname>Bolca</surname><given-names>S.</given-names></name><name><surname>Eeckhaut</surname><given-names>E.</given-names></name><name><surname>Depypere</surname><given-names>H.</given-names></name><name><surname>Verstraete</surname><given-names>W.</given-names></name></person-group><article-title>Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: Producer phenotyping and relation with intestinal community</article-title><source>FEMS Microbiol. Ecol.</source><year>2007</year><volume>61</volume><fpage>372</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6941.2007.00330.x</pub-id><?supplied-pmid 17506823?><pub-id pub-id-type="pmid">17506823</pub-id></element-citation></ref><ref id="B36-molecules-25-05709"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knudsen</surname><given-names>K.E.B.</given-names></name><name><surname>Serena</surname><given-names>A.</given-names></name><name><surname>Kjaer</surname><given-names>A.K.B.</given-names></name><name><surname>Tetens</surname><given-names>I.</given-names></name><name><surname>Heinonen</surname><given-names>S.-M.</given-names></name><name><surname>Nurmi</surname><given-names>T.</given-names></name><name><surname>Adlercreutz</surname><given-names>H.</given-names></name></person-group><article-title>Rye bread in the diet of pigs enhances the formation of enterolactone and increases its levels in plasma, urine and feces</article-title><source>J. Nutr.</source><year>2003</year><volume>133</volume><fpage>1368</fpage><lpage>1375</lpage><pub-id pub-id-type="doi">10.1093/jn/133.5.1368</pub-id><?supplied-pmid 12730424?><pub-id pub-id-type="pmid">12730424</pub-id></element-citation></ref><ref id="B37-molecules-25-05709"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinonen</surname><given-names>S.</given-names></name><name><surname>Nurmi</surname><given-names>T.</given-names></name><name><surname>Liukkonen</surname><given-names>K.</given-names></name><name><surname>Poutanen</surname><given-names>K.</given-names></name><name><surname>W&#x000e4;h&#x000e4;l&#x000e4;</surname><given-names>K.</given-names></name><name><surname>Deyama</surname><given-names>T.</given-names></name><name><surname>Nishibe</surname><given-names>S.</given-names></name><name><surname>Adlercreutz</surname><given-names>H.</given-names></name></person-group><article-title>In vitro metabolism of plant lignans: New precursors of mammalian lignans enterolactone and enterodiol</article-title><source>J. Agric. Food Chem.</source><year>2001</year><volume>49</volume><fpage>3178</fpage><lpage>3186</lpage><pub-id pub-id-type="doi">10.1021/jf010038a</pub-id><?supplied-pmid 11453749?><pub-id pub-id-type="pmid">11453749</pub-id></element-citation></ref><ref id="B38-molecules-25-05709"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hullar</surname><given-names>M.A.J.</given-names></name><name><surname>Lancaster</surname><given-names>S.M.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Tseng</surname><given-names>E.</given-names></name><name><surname>Beer</surname><given-names>K.</given-names></name><name><surname>Atkinson</surname><given-names>C.</given-names></name><name><surname>W&#x000e4;h&#x000e4;l&#x000e4;</surname><given-names>K.</given-names></name><name><surname>Copeland</surname><given-names>W.K.</given-names></name><name><surname>Randolph</surname><given-names>T.W.</given-names></name><name><surname>Newton</surname><given-names>K.M.</given-names></name><etal/></person-group><article-title>Enterolignan-producing phenotypes are associated with increased gut microbial diversity and altered composition in premenopausal women in the united states</article-title><source>Cancer Epidemiol. Biomarkers Prev.</source><year>2004</year><volume>24</volume><fpage>546</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-14-0262</pub-id></element-citation></ref><ref id="B39-molecules-25-05709"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knust</surname><given-names>U.</given-names></name><name><surname>Spiegelhalder</surname><given-names>B.</given-names></name><name><surname>Strowitzki</surname><given-names>T.</given-names></name><name><surname>Owen</surname><given-names>R.W.</given-names></name></person-group><article-title>Contribution of linseed intake to urine and serum enterolignan levels in German females: A randomised controlled intervention trial</article-title><source>Food Chem. Toxicol.</source><year>2006</year><volume>44</volume><fpage>1057</fpage><lpage>1064</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2005.12.009</pub-id><pub-id pub-id-type="pmid">16494982</pub-id></element-citation></ref><ref id="B40-molecules-25-05709"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pe&#x000f1;alvo</surname><given-names>J.L.</given-names></name><name><surname>Heinonen</surname><given-names>S.-M.</given-names></name><name><surname>Aura</surname><given-names>A.-M.</given-names></name><name><surname>Adlercreutz</surname><given-names>H.</given-names></name></person-group><article-title>Dietary sesamin is converted to enterolactone in humans</article-title><source>J. Nutr.</source><year>2005</year><volume>135</volume><fpage>1056</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1093/jn/135.5.1056</pub-id><pub-id pub-id-type="pmid">15867281</pub-id></element-citation></ref><ref id="B41-molecules-25-05709"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saarinen</surname><given-names>N.M.</given-names></name><name><surname>Smeds</surname><given-names>A.</given-names></name><name><surname>M&#x000e4;kel&#x000e4;</surname><given-names>S.I.</given-names></name><name><surname>&#x000c4;mm&#x000e4;l&#x000e4;</surname><given-names>J.</given-names></name><name><surname>Hakala</surname><given-names>K.</given-names></name><name><surname>Pihlava</surname><given-names>J.M.</given-names></name><name><surname>Ryh&#x000e4;nen</surname><given-names>E.L.</given-names></name><name><surname>Sj&#x000f6;holm</surname><given-names>R.</given-names></name><name><surname>Santti</surname><given-names>R.</given-names></name></person-group><article-title>Structural determinants of plant lignans for the formation of enterolactone in vivo</article-title><source>J. Chromatogr. B</source><year>2002</year><volume>777</volume><fpage>311</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/S1570-0232(02)00339-2</pub-id></element-citation></ref><ref id="B42-molecules-25-05709"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klingbeil</surname><given-names>E.</given-names></name><name><surname>De La Serre</surname><given-names>C.B.</given-names></name></person-group><article-title>Microbiota modulation by eating patterns and diet composition: Impact on food intake</article-title><source>Am. J. Physiol. Regul. Integr. Comp. Physiol.</source><year>2018</year><volume>315</volume><fpage>R1254</fpage><lpage>R1260</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00037.2018</pub-id><pub-id pub-id-type="pmid">30230934</pub-id></element-citation></ref><ref id="B43-molecules-25-05709"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.-Q.</given-names></name><name><surname>Zhang</surname><given-names>A.-H.</given-names></name><name><surname>Miao</surname><given-names>J.-H.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>G.-L.</given-names></name><name><surname>Wu</surname><given-names>F.-F.</given-names></name><name><surname>Wang</surname><given-names>X.-J.</given-names></name></person-group><article-title>Gut microbiota as important modulator of metabolism in health and disease</article-title><source>RSC Adv.</source><year>2018</year><volume>8</volume><fpage>42380</fpage><lpage>42389</lpage><pub-id pub-id-type="doi">10.1039/C8RA08094A</pub-id></element-citation></ref><ref id="B44-molecules-25-05709"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>A.</given-names></name><name><surname>Inoue</surname><given-names>R.</given-names></name><name><surname>Inatomi</surname><given-names>O.</given-names></name><name><surname>Bamba</surname><given-names>S.</given-names></name><name><surname>Naito</surname><given-names>Y.</given-names></name><name><surname>Andoh</surname><given-names>A.</given-names></name></person-group><article-title>Gut microbiota in the pathogenesis of inflammatory bowel disease</article-title><source>Clin. J. Gastroenterol.</source><year>2018</year><volume>11</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1007/s12328-017-0813-5</pub-id><pub-id pub-id-type="pmid">29285689</pub-id></element-citation></ref><ref id="B45-molecules-25-05709"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hjorth</surname><given-names>M.F.</given-names></name><name><surname>Roager</surname><given-names>H.M.</given-names></name><name><surname>Larsen</surname><given-names>T.M.</given-names></name><name><surname>Poulsen</surname><given-names>S.K.</given-names></name><name><surname>Licht</surname><given-names>T.R.</given-names></name><name><surname>Bahl</surname><given-names>M.I.</given-names></name><name><surname>Zohar</surname><given-names>Y.</given-names></name><name><surname>Astrup</surname><given-names>A.</given-names></name></person-group><article-title>Pre-treatment microbial Prevotella-to-Bacteroides ratio, determines body fat loss success during a 6-month randomized controlled diet intervention</article-title><source>Int. J. Obes.</source><year>2018</year><volume>42</volume><fpage>580</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1038/ijo.2017.220</pub-id></element-citation></ref><ref id="B46-molecules-25-05709"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>L.</given-names></name><name><surname>Roager</surname><given-names>H.M.</given-names></name><name><surname>Astrup</surname><given-names>A.</given-names></name><name><surname>Hjorth</surname><given-names>M.F.</given-names></name></person-group><article-title>Microbial enterotypes in personalized nutrition and obesity management</article-title><source>Am. J. Clin. Nutr.</source><year>2018</year><volume>108</volume><fpage>645</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1093/ajcn/nqy175</pub-id><pub-id pub-id-type="pmid">30239555</pub-id></element-citation></ref><ref id="B47-molecules-25-05709"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnorr</surname><given-names>S.L.</given-names></name><name><surname>Candela</surname><given-names>M.</given-names></name><name><surname>Rampelli</surname><given-names>S.</given-names></name><name><surname>Centanni</surname><given-names>M.</given-names></name><name><surname>Consolandi</surname><given-names>C.</given-names></name><name><surname>Basaglia</surname><given-names>G.</given-names></name><name><surname>Turroni</surname><given-names>S.</given-names></name><name><surname>Biagi</surname><given-names>E.</given-names></name><name><surname>Peano</surname><given-names>C.</given-names></name><name><surname>Severgnini</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Gut microbiome of the Hadza hunter-gatherers</article-title><source>Nat. Commun.</source><year>2014</year><volume>5</volume><fpage>3654</fpage><pub-id pub-id-type="doi">10.1038/ncomms4654</pub-id><pub-id pub-id-type="pmid">24736369</pub-id></element-citation></ref><ref id="B48-molecules-25-05709"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Filippo</surname><given-names>C.</given-names></name><name><surname>Cavalieri</surname><given-names>D.</given-names></name><name><surname>Di Paola</surname><given-names>M.</given-names></name><name><surname>Ramazzotti</surname><given-names>M.</given-names></name><name><surname>Poullet</surname><given-names>J.B.</given-names></name><name><surname>Massart</surname><given-names>S.</given-names></name><name><surname>Collini</surname><given-names>S.</given-names></name><name><surname>Pieraccini</surname><given-names>G.</given-names></name><name><surname>Lionetti</surname><given-names>P.</given-names></name></person-group><article-title>Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>14691</fpage><lpage>14696</lpage><pub-id pub-id-type="doi">10.1073/pnas.1005963107</pub-id><pub-id pub-id-type="pmid">20679230</pub-id></element-citation></ref><ref id="B49-molecules-25-05709"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bess</surname><given-names>E.N.</given-names></name><name><surname>Bisanz</surname><given-names>J.E.</given-names></name><name><surname>Yarza</surname><given-names>F.</given-names></name><name><surname>Bustion</surname><given-names>A.E.</given-names></name><name><surname>Rich</surname><given-names>B.E.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Kitamura</surname><given-names>S.</given-names></name><name><surname>Waligurski</surname><given-names>E.</given-names></name><name><surname>Ang</surname><given-names>Q.Y.</given-names></name><name><surname>Alba</surname><given-names>D.L.</given-names></name><etal/></person-group><article-title>Genetic basis for the cooperative bioactivation of plant lignans by <italic>Eggerthella lenta</italic> and other human gut bacteria</article-title><source>Nat. Microbiol.</source><year>2020</year><volume>5</volume><fpage>56</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0596-1</pub-id><pub-id pub-id-type="pmid">31686027</pub-id></element-citation></ref><ref id="B50-molecules-25-05709"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clavel</surname><given-names>T.</given-names></name><name><surname>Dor&#x000e9;</surname><given-names>J.</given-names></name><name><surname>Blaut</surname><given-names>M.</given-names></name></person-group><article-title>Bioavailability of lignans in human subjects</article-title><source>Nutr. Res. Rev.</source><year>2006</year><volume>19</volume><fpage>187</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1017/S0954422407249704</pub-id><pub-id pub-id-type="pmid">19079885</pub-id></element-citation></ref><ref id="B51-molecules-25-05709"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nose</surname><given-names>M.</given-names></name><name><surname>Fujimoto</surname><given-names>T.</given-names></name><name><surname>Takeda</surname><given-names>T.</given-names></name><name><surname>Nishibe</surname><given-names>S.</given-names></name><name><surname>Ogihara</surname><given-names>Y.</given-names></name></person-group><article-title>Structural transformation of lignan compounds in rat gastrointestinal tract</article-title><source>Planta Med.</source><year>1992</year><volume>58</volume><fpage>520</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1055/s-2006-961540</pub-id><pub-id pub-id-type="pmid">1336605</pub-id></element-citation></ref><ref id="B52-molecules-25-05709"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>D.</given-names></name><name><surname>Vaghasiya</surname><given-names>J.</given-names></name><name><surname>Pancholi</surname><given-names>S.S.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name></person-group><article-title>Therapeutic potential of secoisolariciresinol diglucoside: A plant lignan</article-title><source>Int. J. Pharm. Sci. Drug Res.</source><year>2012</year><volume>4</volume><fpage>15</fpage><lpage>18</lpage></element-citation></ref><ref id="B53-molecules-25-05709"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.-Q.</given-names></name><name><surname>Meselhy</surname><given-names>M.R.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>G.-W.</given-names></name><name><surname>Hattori</surname><given-names>M.</given-names></name></person-group><article-title>Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone</article-title><source>Chem. Pharm. Bull.</source><year>2000</year><volume>48</volume><fpage>1606</fpage><lpage>1610</lpage><pub-id pub-id-type="doi">10.1248/cpb.48.1606</pub-id></element-citation></ref><ref id="B54-molecules-25-05709"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Studenik</surname><given-names>S.</given-names></name><name><surname>Vogel</surname><given-names>M.</given-names></name><name><surname>Diekert</surname><given-names>G.</given-names></name></person-group><article-title>Characterization of an O-demethylase of <italic>Desulfitobacterium hafniense</italic> DCB-2</article-title><source>J. Bacteriol.</source><year>2012</year><volume>194</volume><fpage>3317</fpage><lpage>3326</lpage><pub-id pub-id-type="doi">10.1128/JB.00146-12</pub-id><pub-id pub-id-type="pmid">22522902</pub-id></element-citation></ref><ref id="B55-molecules-25-05709"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelmann</surname><given-names>T.</given-names></name><name><surname>Kaufmann</surname><given-names>F.</given-names></name><name><surname>Diekert</surname><given-names>G.</given-names></name></person-group><article-title>Isolation and characterization of a veratrol:corrinoid protein methyl transferase from <italic>Acetobacterium dehalogenans</italic></article-title><source>Arch. Microbiol.</source><year>2001</year><volume>175</volume><fpage>376</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1007/s002030100275</pub-id><pub-id pub-id-type="pmid">11409548</pub-id></element-citation></ref><ref id="B56-molecules-25-05709"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>F.</given-names></name><name><surname>Wohlfarth</surname><given-names>G.</given-names></name><name><surname>Diekert</surname><given-names>G.</given-names></name></person-group><article-title>Isolation of O-demethylase, an ether-cleaving enzyme system of the homoacetogenic strain MC</article-title><source>Arch. Microbiol.</source><year>1997</year><volume>168</volume><fpage>136</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1007/s002030050479</pub-id><pub-id pub-id-type="pmid">9238105</pub-id></element-citation></ref><ref id="B57-molecules-25-05709"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naidu</surname><given-names>D.</given-names></name><name><surname>Ragsdale</surname><given-names>S.W.</given-names></name></person-group><article-title>Characterization of a three-component vanillate O-demethylase from <italic>Moorella thermoacetica</italic></article-title><source>J. Bacteriol.</source><year>2001</year><volume>183</volume><fpage>3276</fpage><lpage>3281</lpage><pub-id pub-id-type="doi">10.1128/JB.183.11.3276-3281.2001</pub-id><pub-id pub-id-type="pmid">11344134</pub-id></element-citation></ref><ref id="B58-molecules-25-05709"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.-X.</given-names></name><name><surname>Deng</surname><given-names>C.-Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.-T.</given-names></name><name><surname>Liu</surname><given-names>Z.-M.</given-names></name><name><surname>Wang</surname><given-names>P.-Z.</given-names></name><name><surname>Liu</surname><given-names>S.-L.</given-names></name><name><surname>Qian</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>D.-H.</given-names></name></person-group><article-title>Cloning, expression, and characterization of a four-component O-demethylase from human intestinal bacterium <italic>Eubacterium limosum</italic> ZL-II</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2016</year><volume>100</volume><fpage>9111</fpage><lpage>9124</lpage><pub-id pub-id-type="doi">10.1007/s00253-016-7626-1</pub-id><pub-id pub-id-type="pmid">27236811</pub-id></element-citation></ref><ref id="B59-molecules-25-05709"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaya</surname><given-names>P.</given-names></name><name><surname>Medina</surname><given-names>M.</given-names></name><name><surname>S&#x000e1;nchez-Jim&#x000e9;nez</surname><given-names>A.</given-names></name><name><surname>Landete</surname><given-names>J.M.</given-names></name></person-group><article-title>Phytoestrogen metabolism by adult human gut microbiota</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>1034</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21081034</pub-id></element-citation></ref><ref id="B60-molecules-25-05709"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woting</surname><given-names>A.</given-names></name><name><surname>Clavel</surname><given-names>T.</given-names></name><name><surname>Loh</surname><given-names>G.</given-names></name><name><surname>Blaut</surname><given-names>M.</given-names></name></person-group><article-title>Bacterial transformation of dietary lignans in gnotobiotic rats</article-title><source>FEMS Microbiol. Ecol.</source><year>2010</year><volume>72</volume><fpage>507</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6941.2010.00863.x</pub-id><?supplied-pmid 20370826?><pub-id pub-id-type="pmid">20370826</pub-id></element-citation></ref><ref id="B61-molecules-25-05709"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueira</surname><given-names>I.</given-names></name><name><surname>Garcia</surname><given-names>G.</given-names></name><name><surname>Pimp&#x000e3;o</surname><given-names>R.C.</given-names></name><name><surname>Terrasso</surname><given-names>A.P.</given-names></name><name><surname>Costa</surname><given-names>I.</given-names></name><name><surname>Almeida</surname><given-names>A.F.</given-names></name><name><surname>Tavares</surname><given-names>L.</given-names></name><name><surname>Pais</surname><given-names>T.F.</given-names></name><name><surname>Pinto</surname><given-names>P.</given-names></name><name><surname>Ventura</surname><given-names>M.R.</given-names></name><etal/></person-group><article-title>Polyphenols journey through blood-brain barrier towards neuronal protection</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1038/s41598-017-11512-6</pub-id><pub-id pub-id-type="pmid">28127051</pub-id></element-citation></ref><ref id="B62-molecules-25-05709"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Luo</surname><given-names>M.</given-names></name><name><surname>Wei</surname><given-names>S.</given-names></name></person-group><article-title>The bioprotective effects of polyphenols on metabolic syndrome against oxidative stress: Evidences and perspectives</article-title><source>Oxidative Med. Cell. Longev.</source><year>2019</year><volume>2019</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1155/2019/6713194</pub-id></element-citation></ref><ref id="B63-molecules-25-05709"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>V.P.</given-names></name><name><surname>Aryal</surname><given-names>P.</given-names></name><name><surname>Robinson</surname><given-names>S.</given-names></name><name><surname>Rafiu</surname><given-names>R.</given-names></name><name><surname>Obrenovich</surname><given-names>M.</given-names></name><name><surname>Perry</surname><given-names>G.</given-names></name></person-group><article-title>Polyphenols in Alzheimer&#x02019;s disease and in the gut-brain axis</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>199</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8020199</pub-id></element-citation></ref><ref id="B64-molecules-25-05709"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crispi</surname><given-names>S.</given-names></name><name><surname>Filosa</surname><given-names>S.</given-names></name><name><surname>Di Meo</surname><given-names>F.</given-names></name></person-group><article-title>Polyphenols-gut microbiota interplay and brain neuromodulation</article-title><source>Neural Regen. Res.</source><year>2018</year><volume>13</volume><fpage>2055</fpage><lpage>2059</lpage><pub-id pub-id-type="doi">10.4103/1673-5374.241429</pub-id><pub-id pub-id-type="pmid">30323120</pub-id></element-citation></ref><ref id="B65-molecules-25-05709"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witkowska</surname><given-names>A.M.</given-names></name><name><surname>Wa&#x0015b;kiewicz</surname><given-names>A.</given-names></name><name><surname>Zujko</surname><given-names>M.E.</given-names></name><name><surname>Szcze&#x0015b;niewska</surname><given-names>D.</given-names></name><name><surname>Stepaniak</surname><given-names>U.</given-names></name><name><surname>Paj&#x00105;k</surname><given-names>A.</given-names></name><name><surname>Drygas</surname><given-names>W.</given-names></name></person-group><article-title>Are total and individual dietary lignans related to cardiovascular disease and its risk factors in postmenopausal women? A nationwide study</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><elocation-id>865</elocation-id><pub-id pub-id-type="doi">10.3390/nu10070865</pub-id></element-citation></ref><ref id="B66-molecules-25-05709"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L.</given-names></name><name><surname>Cao</surname><given-names>W.</given-names></name><name><surname>Chi</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name></person-group><article-title>Whole cereal grains and potential health effects: Involvement of the gut microbiota</article-title><source>Food Res. Int.</source><year>2018</year><volume>103</volume><fpage>84</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2017.10.025</pub-id><pub-id pub-id-type="pmid">29389647</pub-id></element-citation></ref><ref id="B67-molecules-25-05709"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creus-Cuadros</surname><given-names>A.</given-names></name><name><surname>Tresserra-Rimbau</surname><given-names>A.</given-names></name><name><surname>Quifer-Rada</surname><given-names>P.</given-names></name><name><surname>Mart&#x000ed;nez-Gonz&#x000e1;lez</surname><given-names>M.A.</given-names></name><name><surname>Corella</surname><given-names>D.</given-names></name><name><surname>Salas-Salvad&#x000f3;</surname><given-names>J.</given-names></name><name><surname>Fit&#x000f3;</surname><given-names>M.</given-names></name><name><surname>Estruch</surname><given-names>R.</given-names></name><name><surname>G&#x000f3;mez-Gracia</surname><given-names>E.</given-names></name><name><surname>Lapetra</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Associations between both lignan and yogurt consumption and cardiovascular risk parameters in an elderly population: Observations from a cross-sectional approach in the PREDIMED study</article-title><source>J. Acad. Nutr. Diet.</source><year>2017</year><volume>117</volume><fpage>609</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1016/j.jand.2016.11.003</pub-id><pub-id pub-id-type="pmid">28041856</pub-id></element-citation></ref><ref id="B68-molecules-25-05709"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Shan</surname><given-names>B.</given-names></name><name><surname>Zeng</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Jin</surname><given-names>C.</given-names></name><name><surname>Liao</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Zeng</surname><given-names>Q.</given-names></name><name><surname>He</surname><given-names>H.</given-names></name><name><surname>Wei</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Raw and wine processed <italic>Schisandra chinensis</italic> attenuate anxiety like behavior via modulating gut microbiota and lipid metabolism pathway</article-title><source>J. Ethnopharmacol.</source><year>2020</year><volume>266</volume><fpage>113426</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2020.113426</pub-id><pub-id pub-id-type="pmid">33007392</pub-id></element-citation></ref><ref id="B69-molecules-25-05709"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soleymani</surname><given-names>S.</given-names></name><name><surname>Habtemariam</surname><given-names>S.</given-names></name><name><surname>Rahimi</surname><given-names>R.</given-names></name><name><surname>Nabavi</surname><given-names>S.M.</given-names></name></person-group><article-title>The what and who of dietary lignans in human health: Special focus on prooxidant and antioxidant effects</article-title><source>Trends Food Sci. Technol.</source><year>2020</year><volume>106</volume><fpage>382</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1016/j.tifs.2020.10.015</pub-id></element-citation></ref><ref id="B70-molecules-25-05709"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>D.</given-names></name><name><surname>Almeida</surname><given-names>L.M.</given-names></name><name><surname>Dinis</surname><given-names>T.C.P.</given-names></name></person-group><article-title>Dietary polyphenols: A novel strategy to modulate microbiota-gut-brain axis</article-title><source>Trends Food Sci. Technol.</source><year>2018</year><volume>78</volume><fpage>224</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.tifs.2018.06.007</pub-id></element-citation></ref><ref id="B71-molecules-25-05709"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>M.</given-names></name><name><surname>Devi</surname><given-names>K.P.</given-names></name></person-group><article-title>A mini review on the protective effect of lignans for the treatment of neurodegenerative disorders</article-title><source>J. Nutr. Food Lipid Sci.</source><year>2019</year><volume>2019</volume><fpage>40</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.33513/nfls/1901-06</pub-id></element-citation></ref><ref id="B72-molecules-25-05709"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bondonno</surname><given-names>C.P.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Croft</surname><given-names>K.D.</given-names></name><name><surname>Considine</surname><given-names>M.J.</given-names></name><name><surname>Ward</surname><given-names>N.C.</given-names></name><name><surname>Rich</surname><given-names>L.</given-names></name><name><surname>Puddey</surname><given-names>I.B.</given-names></name><name><surname>Swinny</surname><given-names>E.</given-names></name><name><surname>Mubarak</surname><given-names>A.</given-names></name><name><surname>Hodgson</surname><given-names>J.M.</given-names></name></person-group><article-title>Flavonoid-rich apples and nitrate-rich spinach augment nitric oxide status and improve endothelial function in healthy men and women: A randomized controlled trial</article-title><source>Free Radic. Biol. Med.</source><year>2012</year><volume>52</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.09.028</pub-id><?supplied-pmid 22019438?><pub-id pub-id-type="pmid">22019438</pub-id></element-citation></ref><ref id="B73-molecules-25-05709"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laranjinha</surname><given-names>J.</given-names></name><name><surname>Santos</surname><given-names>R.M.</given-names></name><name><surname>Louren&#x000e7;o</surname><given-names>C.F.</given-names></name><name><surname>Ledo</surname><given-names>A.</given-names></name><name><surname>Barbosa</surname><given-names>R.M.</given-names></name></person-group><article-title>Nitric oxide signaling in the brain: Translation of dynamics into respiration control and neurovascular coupling</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2012</year><volume>1259</volume><fpage>10</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06582.x</pub-id><?supplied-pmid 22758631?><pub-id pub-id-type="pmid">22758631</pub-id></element-citation></ref><ref id="B74-molecules-25-05709"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Q.</given-names></name><name><surname>Xing</surname><given-names>C.</given-names></name><name><surname>Long</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>H.Y.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>R.-F.</given-names></name></person-group><article-title>Impact of microbiota on central nervous system and neurological diseases: The gut-brain axis</article-title><source>J. Neuroinflammation</source><year>2019</year><volume>16</volume><fpage>53</fpage><pub-id pub-id-type="doi">10.1186/s12974-019-1434-3</pub-id><?supplied-pmid 30823925?><pub-id pub-id-type="pmid">30823925</pub-id></element-citation></ref><ref id="B75-molecules-25-05709"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>P.A.</given-names></name></person-group><article-title>The tantalizing links between gut microbes and the brain</article-title><source>Nature</source><year>2015</year><volume>526</volume><fpage>312</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1038/526312a</pub-id><pub-id pub-id-type="pmid">26469024</pub-id></element-citation></ref><ref id="B76-molecules-25-05709"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>G.</given-names></name><name><surname>Sampson</surname><given-names>T.R.</given-names></name><name><surname>Geschwind</surname><given-names>D.H.</given-names></name><name><surname>Mazmanian</surname><given-names>S.K.</given-names></name></person-group><article-title>The central nervous system and the gut microbiome</article-title><source>Cell</source><year>2016</year><volume>167</volume><fpage>915</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.027</pub-id><pub-id pub-id-type="pmid">27814521</pub-id></element-citation></ref><ref id="B77-molecules-25-05709"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cussotto</surname><given-names>S.</given-names></name><name><surname>Sandhu</surname><given-names>K.V.</given-names></name><name><surname>Dinan</surname><given-names>T.G.</given-names></name><name><surname>Cryan</surname><given-names>J.F.</given-names></name></person-group><article-title>The neuroendocrinology of the microbiota-gut-brain axis: A behavioral perspective</article-title><source>Front. Neuroendocrinol.</source><year>2018</year><volume>51</volume><fpage>80</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.yfrne.2018.04.002</pub-id><pub-id pub-id-type="pmid">29753796</pub-id></element-citation></ref><ref id="B78-molecules-25-05709"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsythe</surname><given-names>P.</given-names></name><name><surname>Bienenstock</surname><given-names>J.</given-names></name><name><surname>Kunze</surname><given-names>W.A.</given-names></name></person-group><article-title>Vagal pathways for microbiome-brain-gut axis communication</article-title><source>Adv. Exp. Med. Biol.</source><year>2014</year><volume>817</volume><fpage>115</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-0897-4_5</pub-id><pub-id pub-id-type="pmid">24997031</pub-id></element-citation></ref><ref id="B79-molecules-25-05709"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonaz</surname><given-names>B.</given-names></name><name><surname>Sinniger</surname><given-names>V.</given-names></name><name><surname>Pellissier</surname><given-names>S.</given-names></name></person-group><article-title>The vagus nerve in the neuro-immune axis: Implications in the pathology of the gastrointestinal tract</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><fpage>1452</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.01452</pub-id><pub-id pub-id-type="pmid">29163522</pub-id></element-citation></ref><ref id="B80-molecules-25-05709"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonaz</surname><given-names>B.</given-names></name><name><surname>Sinniger</surname><given-names>V.</given-names></name><name><surname>Pellissier</surname><given-names>S.</given-names></name></person-group><article-title>Vagus nerve stimulation: A new promising therapeutic tool in inflammatory bowel disease</article-title><source>J. Intern. Med.</source><year>2017</year><volume>282</volume><fpage>46</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1111/joim.12611</pub-id><pub-id pub-id-type="pmid">28421634</pub-id></element-citation></ref><ref id="B81-molecules-25-05709"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travagli</surname><given-names>R.A.</given-names></name><name><surname>Anselmi</surname><given-names>L.</given-names></name></person-group><article-title>Vagal neurocircuitry and its influence on gastric motility</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2016</year><volume>13</volume><fpage>389</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2016.76</pub-id><?supplied-pmid 27251213?><pub-id pub-id-type="pmid">27251213</pub-id></element-citation></ref><ref id="B82-molecules-25-05709"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieder</surname><given-names>R.</given-names></name><name><surname>Wisniewski</surname><given-names>P.J.</given-names></name><name><surname>Alderman</surname><given-names>B.L.</given-names></name><name><surname>Campbell</surname><given-names>S.C.</given-names></name></person-group><article-title>Microbes and mental health: A review</article-title><source>Brain Behav. Immun.</source><year>2017</year><volume>66</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2017.01.016</pub-id><?supplied-pmid 28131791?><pub-id pub-id-type="pmid">28131791</pub-id></element-citation></ref><ref id="B83-molecules-25-05709"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farzi</surname><given-names>A.</given-names></name><name><surname>Fr&#x000f6;hlich</surname><given-names>E.E.</given-names></name><name><surname>Holzer</surname><given-names>P.</given-names></name></person-group><article-title>Gut microbiota and the neuroendocrine system</article-title><source>Neurotherapeutics</source><year>2018</year><volume>15</volume><fpage>5</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1007/s13311-017-0600-5</pub-id><?supplied-pmid 29380303?><pub-id pub-id-type="pmid">29380303</pub-id></element-citation></ref><ref id="B84-molecules-25-05709"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohajeri</surname><given-names>M.H.</given-names></name><name><surname>La Fata</surname><given-names>G.</given-names></name><name><surname>Steinert</surname><given-names>R.E.</given-names></name><name><surname>Weber</surname><given-names>P.</given-names></name></person-group><article-title>Relationship between the gut microbiome and brain function</article-title><source>Nutr. Rev.</source><year>2018</year><volume>76</volume><fpage>481</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1093/nutrit/nuy009</pub-id><?supplied-pmid 29701810?><pub-id pub-id-type="pmid">29701810</pub-id></element-citation></ref><ref id="B85-molecules-25-05709"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cani</surname><given-names>P.D.</given-names></name></person-group><article-title>Interactions between gut microbes and host cells control gut barrier and metabolism</article-title><source>Int. J. Obes. Suppl.</source><year>2016</year><volume>6</volume><fpage>S28</fpage><lpage>S31</lpage><pub-id pub-id-type="doi">10.1038/ijosup.2016.6</pub-id><?supplied-pmid 28685027?><pub-id pub-id-type="pmid">28685027</pub-id></element-citation></ref><ref id="B86-molecules-25-05709"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>J.A.</given-names></name><name><surname>Rinaman</surname><given-names>L.</given-names></name><name><surname>Cryan</surname><given-names>J.F.</given-names></name></person-group><article-title>Stress &#x00026; the gut-brain axis: Regulation by the microbiome</article-title><source>Neurobiol. Stress</source><year>2017</year><volume>7</volume><fpage>124</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.ynstr.2017.03.001</pub-id><pub-id pub-id-type="pmid">29276734</pub-id></element-citation></ref><ref id="B87-molecules-25-05709"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>C.R.</given-names></name><name><surname>Osadchiy</surname><given-names>V.</given-names></name><name><surname>Kalani</surname><given-names>A.</given-names></name><name><surname>Mayer</surname><given-names>E.A.</given-names></name></person-group><article-title>The brain-gut-microbiome axis</article-title><source>Cell. Mol. Gastroenterol. Hepatol.</source><year>2018</year><volume>6</volume><fpage>133</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.jcmgh.2018.04.003</pub-id><pub-id pub-id-type="pmid">30023410</pub-id></element-citation></ref><ref id="B88-molecules-25-05709"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carabotti</surname><given-names>M.</given-names></name><name><surname>Scirocco</surname><given-names>A.</given-names></name><name><surname>Maselli</surname><given-names>M.A.</given-names></name><name><surname>Severi</surname><given-names>C.</given-names></name></person-group><article-title>The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems</article-title><source>Ann. Gastroenterol.</source><year>2015</year><volume>28</volume><fpage>203</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">25830558</pub-id></element-citation></ref><ref id="B89-molecules-25-05709"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saulnier</surname><given-names>D.M.</given-names></name><name><surname>Ringel</surname><given-names>Y.</given-names></name><name><surname>Heyman</surname><given-names>M.B.</given-names></name><name><surname>Foster</surname><given-names>J.A.</given-names></name><name><surname>Bercik</surname><given-names>P.</given-names></name><name><surname>Shulman</surname><given-names>R.J.</given-names></name><name><surname>Versalovic</surname><given-names>J.</given-names></name><name><surname>Verdu</surname><given-names>E.F.</given-names></name><name><surname>Dinan</surname><given-names>T.G.</given-names></name><name><surname>Hecht</surname><given-names>G.</given-names></name><etal/></person-group><article-title>The intestinal microbiome, probiotics and prebiotics in neurogastroenterology</article-title><source>Gut Microbes.</source><year>2013</year><volume>4</volume><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.4161/gmic.22973</pub-id><pub-id pub-id-type="pmid">23202796</pub-id></element-citation></ref><ref id="B90-molecules-25-05709"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strandwitz</surname><given-names>P.</given-names></name></person-group><article-title>Neurotransmitter modulation by the gut microbiota</article-title><source>Brain Res.</source><year>2018</year><volume>1693</volume><fpage>128</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2018.03.015</pub-id><pub-id pub-id-type="pmid">29903615</pub-id></element-citation></ref><ref id="B91-molecules-25-05709"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzer</surname><given-names>P.</given-names></name><name><surname>Farzi</surname><given-names>A.</given-names></name></person-group><article-title>Neuropeptides and the microbiota-gut-brain axis</article-title><source>Adv. Exp. Med. Biol.</source><year>2014</year><volume>817</volume><fpage>195</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-0897-4_9</pub-id><?supplied-pmid 24997035?><pub-id pub-id-type="pmid">24997035</pub-id></element-citation></ref><ref id="B92-molecules-25-05709"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cryan</surname><given-names>J.F.</given-names></name><name><surname>Dinan</surname><given-names>T.G.</given-names></name></person-group><article-title>Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour</article-title><source>Nat. Rev. Neurosci.</source><year>2012</year><volume>13</volume><fpage>701</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1038/nrn3346</pub-id><?supplied-pmid 22968153?><pub-id pub-id-type="pmid">22968153</pub-id></element-citation></ref><ref id="B93-molecules-25-05709"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname><given-names>R.</given-names></name><name><surname>Debs</surname><given-names>L.H.</given-names></name><name><surname>Patel</surname><given-names>A.P.</given-names></name><name><surname>Nguyen</surname><given-names>D.</given-names></name><name><surname>Patel</surname><given-names>K.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>G.</given-names></name><name><surname>Grati</surname><given-names>M.</given-names></name><name><surname>Mittal</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>D.</given-names></name><name><surname>Eshraghi</surname><given-names>A.A.</given-names></name><etal/></person-group><article-title>Neurotransmitters: The critical modulators regulating gut-brain axis</article-title><source>J. Cell. Physiol.</source><year>2017</year><volume>232</volume><fpage>2359</fpage><lpage>2372</lpage><pub-id pub-id-type="doi">10.1002/jcp.25518</pub-id><?supplied-pmid 27512962?><pub-id pub-id-type="pmid">27512962</pub-id></element-citation></ref><ref id="B94-molecules-25-05709"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Kawaguchi</surname><given-names>K.</given-names></name><name><surname>Kiyama</surname><given-names>R.</given-names></name></person-group><article-title>Differential and directional estrogenic signaling pathways induced by enterolignans and their precursors</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0171390</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0171390</pub-id><pub-id pub-id-type="pmid">28152041</pub-id></element-citation></ref><ref id="B95-molecules-25-05709"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J.S.</given-names></name><name><surname>Hattori</surname><given-names>M.</given-names></name></person-group><article-title>Further studies on a human intestinal bacterium <italic>Ruminococcus</italic> sp. END-1 for transformation of plant lignans to mammalian lignans</article-title><source>J. Agric. Food Chem.</source><year>2009</year><volume>57</volume><fpage>7537</fpage><lpage>7542</lpage><pub-id pub-id-type="doi">10.1021/jf900902p</pub-id><pub-id pub-id-type="pmid">19630415</pub-id></element-citation></ref><ref id="B96-molecules-25-05709"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikh</surname><given-names>M.</given-names></name><name><surname>Maddaford</surname><given-names>T.G.</given-names></name><name><surname>Austria</surname><given-names>J.A.</given-names></name><name><surname>Aliani</surname><given-names>M.</given-names></name><name><surname>Netticadan</surname><given-names>T.</given-names></name><name><surname>Pierce</surname><given-names>G.N.</given-names></name></person-group><article-title>Dietary flaxseed as a strategy for improving human health</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>1171</elocation-id><pub-id pub-id-type="doi">10.3390/nu11051171</pub-id></element-citation></ref><ref id="B97-molecules-25-05709"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Zeng</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Mastriani</surname><given-names>E.</given-names></name><name><surname>Li</surname><given-names>Q.-H.</given-names></name><name><surname>Bao</surname><given-names>H.-X.</given-names></name><name><surname>Zhou</surname><given-names>Y.-J.</given-names></name><etal/></person-group><article-title>Enterolactone has stronger effects than enterodiol on ovarian cancer</article-title><source>J. Ovarian Res.</source><year>2017</year><volume>10</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/s13048-017-0346-z</pub-id><pub-id pub-id-type="pmid">28086946</pub-id></element-citation></ref><ref id="B98-molecules-25-05709"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezzat</surname><given-names>S.M.</given-names></name><name><surname>Shouman</surname><given-names>S.A.</given-names></name><name><surname>ElKhoely</surname><given-names>A.</given-names></name><name><surname>Attia</surname><given-names>Y.M.</given-names></name><name><surname>Elsesy</surname><given-names>M.E.</given-names></name><name><surname>El Senousy</surname><given-names>A.S.</given-names></name><name><surname>Choucry</surname><given-names>M.A.</given-names></name><name><surname>El Gayed</surname><given-names>S.H.</given-names></name><name><surname>El Sayed</surname><given-names>A.A.</given-names></name><name><surname>Sattar</surname><given-names>E.A.</given-names></name><etal/></person-group><article-title>Anticancer potentiality of lignan rich fraction of six Flaxseed cultivars</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>544</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-18944-0</pub-id><pub-id pub-id-type="pmid">29323210</pub-id></element-citation></ref><ref id="B99-molecules-25-05709"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.-H.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Demark-Wahnefried</surname><given-names>W.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name></person-group><article-title>Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway</article-title><source>Mol. Cancer Ther.</source><year>2007</year><volume>6</volume><fpage>2581</fpage><lpage>2590</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-07-0220</pub-id><pub-id pub-id-type="pmid">17876055</pub-id></element-citation></ref><ref id="B100-molecules-25-05709"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;se</surname><given-names>L.</given-names></name><name><surname>G&#x000fc;l&#x000e7;in</surname><given-names>&#x00130;.</given-names></name></person-group><article-title>Inhibition effects of some lignans on carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase enzymes</article-title><source>Rec. Nat. Prod.</source><year>2017</year><volume>11</volume><fpage>558</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.25135/rnp.71.17.04.074</pub-id></element-citation></ref><ref id="B101-molecules-25-05709"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuong</surname><given-names>T.D.</given-names></name><name><surname>Hung</surname><given-names>T.M.</given-names></name><name><surname>Han</surname><given-names>H.-Y.</given-names></name><name><surname>Roh</surname><given-names>H.S.</given-names></name><name><surname>Seok</surname><given-names>J.-H.</given-names></name><name><surname>Lee</surname><given-names>J.K.</given-names></name><name><surname>Jeong</surname><given-names>J.Y.</given-names></name><name><surname>Choi</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>J.A.</given-names></name><name><surname>Min</surname><given-names>B.S.</given-names></name></person-group><article-title>Potent acetylcholinesterase inhibitory compounds from <italic>Myristica fragrans</italic></article-title><source>Nat. Prod. Commun.</source><year>2014</year><volume>9</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1177/1934578X1400900418</pub-id><?supplied-pmid 24868867?><pub-id pub-id-type="pmid">24868867</pub-id></element-citation></ref><ref id="B102-molecules-25-05709"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Pi</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Yue</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Song</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Systematically characterize the anti-alzheimer&#x02019;s disease mechanism of lignans from <italic>S. chinensis</italic> based on in-vivo ingredient analysis and target-network pharmacology strategy by UHPLC&#x0207b;Q-TOF-MS</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1203</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24071203</pub-id><?supplied-pmid 30934777?><pub-id pub-id-type="pmid">30934777</pub-id></element-citation></ref><ref id="B103-molecules-25-05709"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giuliano</surname><given-names>C.</given-names></name><name><surname>Siani</surname><given-names>F.</given-names></name><name><surname>Mus</surname><given-names>L.</given-names></name><name><surname>Ghezzi</surname><given-names>C.</given-names></name><name><surname>Cerri</surname><given-names>S.</given-names></name><name><surname>Pacchetti</surname><given-names>B.</given-names></name><name><surname>Bigogno</surname><given-names>C.</given-names></name><name><surname>Blandini</surname><given-names>F.</given-names></name></person-group><article-title>Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson&#x02019;s disease</article-title><source>Nutrition</source><year>2020</year><volume>69</volume><fpage>110494</fpage><pub-id pub-id-type="doi">10.1016/j.nut.2019.04.006</pub-id><pub-id pub-id-type="pmid">31586482</pub-id></element-citation></ref><ref id="B104-molecules-25-05709"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esp&#x000ed;n</surname><given-names>J.C.</given-names></name><name><surname>Gonz&#x000e1;lez-Sarr&#x000ed;as</surname><given-names>A.</given-names></name><name><surname>Tom&#x000e1;s-Barber&#x000e1;n</surname><given-names>F.A.</given-names></name></person-group><article-title>The gut microbiota: A key factor in the therapeutic effects of (poly)phenols</article-title><source>Biochem. Pharmacol.</source><year>2017</year><volume>139</volume><fpage>82</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2017.04.033</pub-id><?supplied-pmid 28483461?><pub-id pub-id-type="pmid">28483461</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-05709-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Overview of the colonic pathways involving plant lignans, starting from two parent compounds, namely syringaresinol and pinoresinol.</p></caption><graphic xlink:href="molecules-25-05709-g001"/></fig><fig id="molecules-25-05709-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Schematic representation of the gut microbiota&#x02013;brain interaction, when considering dietary lignans and their gut metabolites (enterodiol and enterolactone). Besides, the main bioactive properties of both parent compounds and gut metabolites are also reported.</p></caption><graphic xlink:href="molecules-25-05709-g002"/></fig><table-wrap id="molecules-25-05709-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-05709-t001_Table 1</object-id><label>Table 1</label><caption><p>Most common lignans in plant foods, together with their structure, class, and major sources, according to the comprehensive Phenol-Explorer database [<xref rid="B4-molecules-25-05709" ref-type="bibr">4</xref>].</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Structure</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Class</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Major Food Sources</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Secoisolariciresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-05709-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dibenzylbutane lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flaxseed (257.6 mg/100 g FW)<break/> Cashew nut (6.7 mg/100 g FW)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Matairesinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-05709-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dibenzylbutyrolactone lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesame seed (29.8 mg/100 FW)<break/> Flaxseed (6.7 mg/100 g FW)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lariciresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-05709-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furan lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broccoli (97.2 mg/100 g FW)<break/> Kale (59.9 mg/100 g FW)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Medioresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-05709-i004.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furofuran lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesame seed (4.1 mg/100 g FW)<break/> Cloudberry (0.48 mg/100 g FW)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pinoresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-05709-i005.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furofuran lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Olive oil (2.4 mg/100 g FW)<break/> EVOO (0.42 mg/100 g FW)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Syringaresinol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-05709-i006.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furofuran lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rye, whole grain flour (0.9 mg/100 g FW)<break/> Avocado (0.4 mg/100 g FW)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesamin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-05709-i007.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furofuran lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesame seed, oil (644.5 mg/100 g FW)<break/> Sesame seed (538.1 mg/100 g FW)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesamolin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-05709-i008.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furofuran lignan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesame seed, oil (287.3 mg/100 g FW)<break/> Sesame seed (133.9 mg/100 g FW)</td></tr></tbody></table></table-wrap><table-wrap id="molecules-25-05709-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-05709-t002_Table 2</object-id><label>Table 2</label><caption><p>Studies summarizing the production of lignan metabolites (enterodiol and enterolactone) following the intake of lignans from different plant foods.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant Lignan Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Experiment Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Findings</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wheat bread; Rye bread</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Crossover intervention using pigs.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Conversion of parent lignans in EL. MAT and SECO showed the higher conversion rate.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B36-molecules-25-05709" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oilseeds mix</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro fermentation using women feces.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower effectiveness in the conversion ED in EL in postmenopausal period.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-molecules-25-05709" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BeneFlax<sup>&#x000ae;</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo study based on healthy adults.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma concentration of flaxseed lignans SECO, ED, and EL correlated with daily oral supplementation of flaxseed lignan&#x02013;enriched complex.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B13-molecules-25-05709" ref-type="bibr">13</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LinumLife Extra</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SHIME (considering low and high enterolignan producers)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Marked differences in EL/ED ratio over the experimental period.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-molecules-25-05709" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Whole flaxseed and flaxseed flour</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro fermentation using pooled human feces.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Major ED production as resulting by flaxseed flour.Similar production of EL for both food matrices.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B10-molecules-25-05709" ref-type="bibr">10</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flaxseed extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro fermentation using children feces.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dihydroxy-ED detected as the major metabolites.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-molecules-25-05709" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single lignan compounds (MAT, SECO, PDG, SYR diglucoside, HMAT).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro fermentation using pooled human feces.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Major conversion rates observed for SECO (72%), MAT (62%), and PDG (55%).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B37-molecules-25-05709" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Habitual diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Food record on urine collected from premenopausal women.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ED was detected over the limit of detection as major metabolite in all urine samples.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-molecules-25-05709" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ground linseed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy women increasing the consumption of fruit and vegetables. Collection of serum and urine samples.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increase in the concentration of ED (as main metabolite) in both serum and urine samples.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B39-molecules-25-05709" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isolate SDG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plasma and urine samples collected from mean and women.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extraction of urinary EL was 2-fold higher than enterodiol. Plasma concentration of ED was higher in women.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B31-molecules-25-05709" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wheat and rye diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Feces and urine collected from pigs.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EL was the predominant circulating lignan found in both biofluids and significantly correlated to the higher plant lignan intake.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-molecules-25-05709" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flaxseed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Collection of serum samples from healthy men.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10-fold increase in serum concentration of ED and EL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B33-molecules-25-05709" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesame, flaxseed and sesame seeds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro fermentation and collection of urine from rats.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Higher conversion rate of parent compounds in ED.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B19-molecules-25-05709" ref-type="bibr">19</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Habitual diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Food record on endoscopy men and women (collection of plasma samples).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Higher levels of EL detected in biofluids.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B28-molecules-25-05709" ref-type="bibr">28</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Whole grains and refined grains</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Food record on urine samples collected from health volunteers.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No linear correlation between lignans intake and EL excretion.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B9-molecules-25-05709" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Habitual diet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Food record on urine samples collected from healthy men.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EL production was correlated with a higher intake of vegetables and berries consumption.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-molecules-25-05709" ref-type="bibr">27</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pure sesamin and sesame seed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro fermentation using pooled human feces.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EL was the main metabolite of sesamin.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B40-molecules-25-05709" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LinumLife<sup>TM</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro fermentation using feces collected from women.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ED detected in higher % when compared with EL. High inter-variability detected.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B35-molecules-25-05709" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SDG and flaxseed consumption</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro fermentation and collection of urine samples.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Great inter- and intra-variability detected when considering the different donors.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B15-molecules-25-05709" ref-type="bibr">15</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single compounds (SECO, HMAT, and MAT)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Urine samples collected from rats.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Different proportions of excreted EL and ED depending on the lignan precursor.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-molecules-25-05709" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flaxseed extracts (high in SDG)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum and urine samples collected from postmenopausal women.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Great dose-response effect observed when considering EL and ED production.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B11-molecules-25-05709" ref-type="bibr">11</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>